WEBVTT - Graham Pechenik on Psychedelic Patents & Law

0:00:00.320 --> 0:00:07.720
<v Speaker 1>Hi, I'm Ethan Nadelman and this is psychoactive, a production

0:00:07.760 --> 0:00:11.600
<v Speaker 1>of I heart radio and protozoa pictures. psychoactive is the

0:00:11.600 --> 0:00:15.040
<v Speaker 1>show where we talk about all things drugs, but any

0:00:15.120 --> 0:00:18.760
<v Speaker 1>views expressed here do not represent those of I heart media,

0:00:18.920 --> 0:00:23.599
<v Speaker 1>protozoa pictures or their executives and employees. Indeed, as an

0:00:23.680 --> 0:00:26.840
<v Speaker 1>inveterate contrarian, I can tell you they may not even

0:00:26.920 --> 0:00:31.120
<v Speaker 1>represent my own, and nothing contained in this show should

0:00:31.120 --> 0:00:34.040
<v Speaker 1>be used as medical advice or encouragement to use any

0:00:34.080 --> 0:00:47.360
<v Speaker 1>type of drugs. Hello, psychoactive listeners. So today's subject is

0:00:47.440 --> 0:00:53.159
<v Speaker 1>the issue of psychedelics and the law, specifically psychedelics and

0:00:53.360 --> 0:00:56.760
<v Speaker 1>Intellectual Property Law, the issue of patents. His name is

0:00:56.800 --> 0:01:00.200
<v Speaker 1>Graham Patch Nick. He's an attorney in San Francisco. We

0:01:00.280 --> 0:01:03.280
<v Speaker 1>founded a law firm about six years ago called Kalix Law,

0:01:03.480 --> 0:01:06.520
<v Speaker 1>C A L Y X, but he's been working in

0:01:06.560 --> 0:01:09.119
<v Speaker 1>the area of patent law now for a couple of

0:01:09.160 --> 0:01:13.640
<v Speaker 1>decades and a whole range of industries, the marijuana industry.

0:01:14.200 --> 0:01:18.800
<v Speaker 1>Uh So, Graham, thanks so much for joining me on psychoactive.

0:01:18.920 --> 0:01:21.679
<v Speaker 1>Thank you so much, Ethan, for the honor of being here.

0:01:21.720 --> 0:01:23.959
<v Speaker 1>It's it's really enjoyed to be able to participate in

0:01:24.000 --> 0:01:27.000
<v Speaker 1>your podcast, which I've enjoyed for so long. Grandma. Want

0:01:27.000 --> 0:01:29.280
<v Speaker 1>to start off by sort of placing the issue of

0:01:29.360 --> 0:01:32.640
<v Speaker 1>psychedelic patents law at the intersection of two things. One

0:01:32.760 --> 0:01:35.480
<v Speaker 1>the broader issue of patent law, which will get into

0:01:35.520 --> 0:01:38.959
<v Speaker 1>broadly because obviously in many respects the issues that are

0:01:38.959 --> 0:01:42.880
<v Speaker 1>emerging in psychedelics patent law are just emblematic of the

0:01:42.920 --> 0:01:46.199
<v Speaker 1>broader issues and challenges and problems in broader patent law.

0:01:46.440 --> 0:01:49.000
<v Speaker 1>But it's also at the intersection of Patent Law and

0:01:49.160 --> 0:01:55.520
<v Speaker 1>of PSYCHEDELIC law, and there's now a psychedelic law association.

0:01:55.960 --> 0:01:58.240
<v Speaker 1>I think they just recently had one of their first

0:01:58.320 --> 0:02:02.440
<v Speaker 1>meetings in September. And so, apart from patent law, what

0:02:02.520 --> 0:02:05.680
<v Speaker 1>are the other issues in psychedelics law? I mean, I

0:02:05.720 --> 0:02:08.640
<v Speaker 1>go back to thinking about those initial religious freedom cases

0:02:08.680 --> 0:02:11.959
<v Speaker 1>involving the churches that we're using Ayahuasca, the UDV and

0:02:12.000 --> 0:02:14.720
<v Speaker 1>the Siento dime. But apart from that religious peace and

0:02:14.760 --> 0:02:17.880
<v Speaker 1>the area you're working on especially now, what else lies

0:02:17.880 --> 0:02:20.800
<v Speaker 1>in that field of psychedelics law? Well, that's a good question,

0:02:20.919 --> 0:02:24.600
<v Speaker 1>and so I say there is the Psychedelic Bar Association,

0:02:24.600 --> 0:02:28.200
<v Speaker 1>which did just have its first psychedelic laws summit, which

0:02:28.200 --> 0:02:32.520
<v Speaker 1>had over three dozen lawyers who have an interest or

0:02:32.720 --> 0:02:34.880
<v Speaker 1>some bit of a practice in psychedelics. And there is

0:02:34.960 --> 0:02:39.240
<v Speaker 1>also actually, where I am a California psychedelics Bar Association

0:02:39.360 --> 0:02:43.440
<v Speaker 1>founded by two psychedelics General Council of two companies. In

0:02:43.520 --> 0:02:45.560
<v Speaker 1>terms of the amount of work actually that people can

0:02:45.639 --> 0:02:48.359
<v Speaker 1>do in terms of a focus, I think you're right

0:02:48.520 --> 0:02:52.320
<v Speaker 1>to call out the religious freedom restoration act and work

0:02:52.320 --> 0:02:55.960
<v Speaker 1>around there, because for many years that, I think, was

0:02:56.480 --> 0:02:59.600
<v Speaker 1>the predominant area. Or if somebody was interested in psychedelics,

0:02:59.639 --> 0:03:03.880
<v Speaker 1>law could work in and I think up until really

0:03:03.919 --> 0:03:06.000
<v Speaker 1>I've had the great fortune of having this niche and

0:03:06.040 --> 0:03:09.200
<v Speaker 1>psychedelics patents there haven't been all that many and certainly

0:03:09.200 --> 0:03:12.639
<v Speaker 1>not ones where one could make an entire practice or

0:03:12.960 --> 0:03:15.600
<v Speaker 1>the entire focus of a career on psychedelics. And actually

0:03:15.639 --> 0:03:20.040
<v Speaker 1>there's an article that just came out recently by Matt Zorne,

0:03:20.240 --> 0:03:24.079
<v Speaker 1>who I worked together with on a challenge against the

0:03:24.160 --> 0:03:26.360
<v Speaker 1>D a. The challenge against the D A was one

0:03:26.400 --> 0:03:28.880
<v Speaker 1>way we could get involved as lawyers who are interested

0:03:28.919 --> 0:03:32.079
<v Speaker 1>in psychedelics. So the DA had proposed to schedule five

0:03:32.080 --> 0:03:35.839
<v Speaker 1>psychedelic trip to means and because Matt is a really

0:03:35.840 --> 0:03:38.440
<v Speaker 1>good d a lawyer and I had an interest in psychedelics.

0:03:38.440 --> 0:03:41.440
<v Speaker 1>We joined horses, along with some others, to challenge that.

0:03:41.680 --> 0:03:44.680
<v Speaker 1>I actually was reading that article that you mentioned, Graham,

0:03:45.000 --> 0:03:48.120
<v Speaker 1>by Matt just last night and prepping for our discussion

0:03:48.160 --> 0:03:51.560
<v Speaker 1>where he talks about the case, about the D E A.

0:03:52.080 --> 0:03:54.200
<v Speaker 1>I mean we've so long seen the D e a

0:03:54.200 --> 0:03:56.560
<v Speaker 1>as the bad guys, you know, trying to throw things

0:03:56.600 --> 0:03:59.960
<v Speaker 1>into schedule one without any proper, you know, do process

0:04:00.000 --> 0:04:03.040
<v Speaker 1>as her hearings. But this more recent case where the

0:04:03.160 --> 0:04:06.160
<v Speaker 1>D A targeted these five trip to mean is a

0:04:06.200 --> 0:04:09.600
<v Speaker 1>certain class of psychedelics and say they want to write

0:04:09.600 --> 0:04:12.120
<v Speaker 1>the schedule one. I remember Hamilton's Morris, you know, who's

0:04:12.280 --> 0:04:14.720
<v Speaker 1>one of my guests on psychoactives, sounding the alarm he

0:04:14.720 --> 0:04:17.039
<v Speaker 1>emailed made lots of other people, got a lot of

0:04:17.040 --> 0:04:20.479
<v Speaker 1>people mobilized and then I think Matt played a key role,

0:04:20.560 --> 0:04:23.960
<v Speaker 1>with assistance from you, in challenging this, hopefuly beating back

0:04:24.040 --> 0:04:26.760
<v Speaker 1>the d e a uh and forcing them not to

0:04:26.839 --> 0:04:29.200
<v Speaker 1>throw these things into schedule one. So wonder if you

0:04:29.200 --> 0:04:32.120
<v Speaker 1>could just tell our listeners to things. One, what was

0:04:32.160 --> 0:04:35.560
<v Speaker 1>special about that fight and secondly, do you think it's

0:04:35.560 --> 0:04:38.280
<v Speaker 1>going to have broader implications in terms of how the

0:04:38.400 --> 0:04:41.880
<v Speaker 1>D e a views other psychedelic substances in the future. Sure.

0:04:42.320 --> 0:04:45.760
<v Speaker 1>And so your first question, what do I think perhaps

0:04:45.920 --> 0:04:49.600
<v Speaker 1>was special about that? I think what was special really

0:04:49.720 --> 0:04:54.120
<v Speaker 1>was the just artillery, so to Speaker, the you know,

0:04:54.200 --> 0:04:57.400
<v Speaker 1>the amount of work that Matt in particular brought to

0:04:57.480 --> 0:05:02.680
<v Speaker 1>bear to this challenge. And so Hamilton Morris, as you mentioned,

0:05:02.720 --> 0:05:07.000
<v Speaker 1>was involved. There was another company, Pantasy of plant sciences,

0:05:07.080 --> 0:05:10.840
<v Speaker 1>and their CEO was very interested in this and it's

0:05:10.800 --> 0:05:13.200
<v Speaker 1>spent a lot of effort even before this had filed

0:05:13.440 --> 0:05:17.560
<v Speaker 1>against the DA. And then we had declarations from uh

0:05:17.640 --> 0:05:22.960
<v Speaker 1>for many experts on the really everything from the fact

0:05:23.040 --> 0:05:27.480
<v Speaker 1>that these particular compounds, we're not ones that had any

0:05:28.200 --> 0:05:32.960
<v Speaker 1>evidence of abuse and didn't pose any threat of safety

0:05:32.960 --> 0:05:37.280
<v Speaker 1>issues or any risks, and the D A's evidence that

0:05:37.400 --> 0:05:41.600
<v Speaker 1>dad was over a decade old, from a report from

0:05:41.640 --> 0:05:47.760
<v Speaker 1>around Um long before this the current wave of psychedelic

0:05:47.800 --> 0:05:50.680
<v Speaker 1>research and the PSYCHEDELIC grandis songs. But Graham, why, why

0:05:50.680 --> 0:05:53.600
<v Speaker 1>were they even bothering to try to throw these five substances,

0:05:53.600 --> 0:05:55.240
<v Speaker 1>and I mean was there was there any evidence that

0:05:55.279 --> 0:05:57.919
<v Speaker 1>they were being misused in the broader public. Yeah, that's

0:05:57.960 --> 0:05:59.680
<v Speaker 1>a really good question and it's not really something that

0:05:59.720 --> 0:06:01.480
<v Speaker 1>we were able to very easily figure out. I mean,

0:06:01.600 --> 0:06:03.320
<v Speaker 1>the reason they had this ten year old report was

0:06:03.360 --> 0:06:06.239
<v Speaker 1>because back in the ats there was something called Operation

0:06:06.360 --> 0:06:10.000
<v Speaker 1>Red trip where the d a went after the vendors

0:06:10.040 --> 0:06:12.760
<v Speaker 1>of research chemicals of different trip to means, and it

0:06:12.760 --> 0:06:16.440
<v Speaker 1>looked like although they had went back then to go

0:06:16.520 --> 0:06:19.480
<v Speaker 1>after some of the ones that had broader use, these

0:06:19.520 --> 0:06:21.240
<v Speaker 1>sort of were left out because I didn't really have

0:06:21.680 --> 0:06:24.599
<v Speaker 1>that many reports of use and the only deaths that

0:06:24.640 --> 0:06:28.760
<v Speaker 1>were on record were poly drug abuse and involving other things.

0:06:28.800 --> 0:06:30.719
<v Speaker 1>But that, I think, still kind of remains a mystery.

0:06:30.760 --> 0:06:34.760
<v Speaker 1>What actually uh initiated this at the beginning of the year.

0:06:35.000 --> 0:06:37.320
<v Speaker 1>So in terms of you were able to beat them back.

0:06:37.440 --> 0:06:40.039
<v Speaker 1>Do you think it's going to impact how the D

0:06:40.080 --> 0:06:43.240
<v Speaker 1>e a operates in the future on other novel compounds,

0:06:43.320 --> 0:06:45.840
<v Speaker 1>especially psychonoloic compounds? Yeah, I mean I think that's really

0:06:45.839 --> 0:06:49.160
<v Speaker 1>a big open question and so this sort of first

0:06:49.600 --> 0:06:51.680
<v Speaker 1>way we thought about trying to see if there would

0:06:51.720 --> 0:06:54.760
<v Speaker 1>be any evidence of an answer was with the second

0:06:54.960 --> 0:06:58.279
<v Speaker 1>challenge there was to the d a. So just after

0:06:58.800 --> 0:07:02.120
<v Speaker 1>the d a proposed schedule these five psychedelic trip to means.

0:07:02.640 --> 0:07:07.280
<v Speaker 1>The D A also proposed to schedule too psychedelic finela means,

0:07:07.360 --> 0:07:11.360
<v Speaker 1>D O I and D c. both, similarly to the

0:07:11.400 --> 0:07:14.320
<v Speaker 1>five trip to means, had had very little evidence of abuse,

0:07:14.360 --> 0:07:19.200
<v Speaker 1>almost none. D O I, however, is something that's in hundreds,

0:07:19.240 --> 0:07:22.640
<v Speaker 1>if not thousands, of publications as a standard in research

0:07:22.760 --> 0:07:27.200
<v Speaker 1>because it's such a good serotonin receptor agonists and because

0:07:27.200 --> 0:07:29.280
<v Speaker 1>it is unscheduled, it's it's very easy to work with,

0:07:29.720 --> 0:07:31.600
<v Speaker 1>and so we were looking out to see if the

0:07:31.720 --> 0:07:35.119
<v Speaker 1>D A's proposal there would would go forward, and actually

0:07:35.160 --> 0:07:38.760
<v Speaker 1>they withdrew that one as well. So it looks like

0:07:38.840 --> 0:07:42.640
<v Speaker 1>maybe with psychedelics there might be some leniency, but I

0:07:42.680 --> 0:07:47.000
<v Speaker 1>think with both they basically didn't say they're they're done entirely,

0:07:47.040 --> 0:07:48.840
<v Speaker 1>but just that they're going back to the drawing board.

0:07:48.920 --> 0:07:51.200
<v Speaker 1>So just briefly explained to the audience the difference between

0:07:51.200 --> 0:07:53.920
<v Speaker 1>the two categories of substance. Yeah, so the difference between

0:07:53.920 --> 0:07:58.480
<v Speaker 1>the two categories is based on the chemical structure, the

0:07:58.560 --> 0:08:01.760
<v Speaker 1>chemical backbone, or scoff hold is some as some call it,

0:08:01.800 --> 0:08:05.440
<v Speaker 1>and TRIPP to means have a chemical backbone that's the

0:08:05.440 --> 0:08:08.840
<v Speaker 1>same as Serotonin. So serotonin actually is for hydroxy, tripp

0:08:08.920 --> 0:08:10.840
<v Speaker 1>to mean. And so you know, we think of a

0:08:10.840 --> 0:08:14.120
<v Speaker 1>lot of psychedelics we know with perhaps tripped to mean

0:08:14.120 --> 0:08:16.000
<v Speaker 1>in the name. So die methyl trip to mean or

0:08:16.120 --> 0:08:19.120
<v Speaker 1>five methoxy trip to mean Um, and so these are

0:08:19.120 --> 0:08:23.280
<v Speaker 1>all tripp to means. LSD, for instance, is generally classed,

0:08:23.680 --> 0:08:25.600
<v Speaker 1>or can be as a trip to mean. It has

0:08:25.640 --> 0:08:28.760
<v Speaker 1>a more complex structure. Um. Even Ibagaine has a trip

0:08:28.800 --> 0:08:31.240
<v Speaker 1>to mean or Indole core as part of it Bein

0:08:31.280 --> 0:08:35.280
<v Speaker 1>ethyl means. Are Compounds that are like mescaline or or

0:08:35.400 --> 0:08:38.800
<v Speaker 1>M D M A, or have a scaffold that's like

0:08:38.920 --> 0:08:44.760
<v Speaker 1>an amphetamine Um, and amphenamine actually stands for an Alpha methylamine.

0:08:44.840 --> 0:08:47.160
<v Speaker 1>So these all have this finethylamine core which is more

0:08:47.200 --> 0:08:51.720
<v Speaker 1>like the dopamine neurotransmitter. So now let's just put this

0:08:51.760 --> 0:08:54.040
<v Speaker 1>into a kind of a little bit of historical context

0:08:54.120 --> 0:08:56.560
<v Speaker 1>with a with a couple of the most famous names

0:08:56.640 --> 0:09:01.760
<v Speaker 1>and psychedelics creation. Right. The first one is Albert Hoffman,

0:09:01.880 --> 0:09:05.960
<v Speaker 1>who was working at Sandaz and sort of discovered or devised,

0:09:05.960 --> 0:09:08.559
<v Speaker 1>however you want to put an LSD during World War

0:09:08.600 --> 0:09:14.320
<v Speaker 1>Two years. So Hoffman and Sandas did patent those things

0:09:14.360 --> 0:09:18.079
<v Speaker 1>back then. Right, those who were among the few patents

0:09:18.120 --> 0:09:22.079
<v Speaker 1>in this area for many decades. Is that right? That's right. Yes,

0:09:22.200 --> 0:09:29.000
<v Speaker 1>so after Albert Hoffman received samples of Psilocybin Mushrooms, actually

0:09:29.040 --> 0:09:32.960
<v Speaker 1>from Gordon Watson, from the same area where Gordon Watson

0:09:33.040 --> 0:09:37.760
<v Speaker 1>went and had his the first time, Um, Albert Hoffman

0:09:37.840 --> 0:09:42.360
<v Speaker 1>and sandals filed patent applications on the the isolation of

0:09:42.520 --> 0:09:46.840
<v Speaker 1>PSILOCYBIN and also its use as a tranquilizer action. But

0:09:46.960 --> 0:09:50.319
<v Speaker 1>were there many, many more psychedelic patents back then, or

0:09:50.360 --> 0:09:53.400
<v Speaker 1>were these really sort of standing alone? For some decades

0:09:53.760 --> 0:09:57.240
<v Speaker 1>these were standing alone, and many people, of course, will know,

0:09:57.280 --> 0:10:00.559
<v Speaker 1>and with Pikel and Tiko, that there were, how underds

0:10:00.600 --> 0:10:05.280
<v Speaker 1>just in those books that were developed by by Sasha. Well,

0:10:05.320 --> 0:10:07.120
<v Speaker 1>I mean you're jumping to my next question here, which is,

0:10:07.160 --> 0:10:09.920
<v Speaker 1>did Sasha Shilgan ever seek or get a patent for

0:10:09.960 --> 0:10:12.240
<v Speaker 1>any of his creations, or do you know, did he

0:10:12.480 --> 0:10:15.480
<v Speaker 1>deliberately choose not to, because those two books, pe call

0:10:15.559 --> 0:10:18.160
<v Speaker 1>and tea call, which are essentially recipe books for hundreds

0:10:18.160 --> 0:10:20.880
<v Speaker 1>of these substances, put it out into the public domain

0:10:21.400 --> 0:10:23.760
<v Speaker 1>and I guess that presumably means they can't be patented

0:10:23.760 --> 0:10:25.679
<v Speaker 1>in the future, at least with the ways that he

0:10:25.800 --> 0:10:28.800
<v Speaker 1>used to synthesize them. But what do you know about

0:10:28.840 --> 0:10:32.520
<v Speaker 1>Sasha's history visa the patent? was He ever ever seeking

0:10:32.520 --> 0:10:35.959
<v Speaker 1>in that area or did he deliberately abstain from seeking that?

0:10:35.760 --> 0:10:39.800
<v Speaker 1>That's a good question actually. Interestingly, part of the reason,

0:10:39.840 --> 0:10:42.520
<v Speaker 1>I think Sasha was even able to do the amount

0:10:42.559 --> 0:10:47.360
<v Speaker 1>of chemistry that he did relating to psychedelics was due

0:10:47.400 --> 0:10:49.840
<v Speaker 1>to the fact that he had some very successful patents

0:10:49.920 --> 0:10:52.720
<v Speaker 1>that he filed when he was working at down and

0:10:53.120 --> 0:10:55.120
<v Speaker 1>those patents earned so much money for the company that

0:10:55.160 --> 0:10:57.040
<v Speaker 1>they gave him a little bit more free reigin with

0:10:57.080 --> 0:10:59.600
<v Speaker 1>his laboratory and allowed him to pursue some other interests.

0:11:00.120 --> 0:11:03.040
<v Speaker 1>In terms of his interest, though, filing patent applications on

0:11:03.040 --> 0:11:05.880
<v Speaker 1>his own. I think it's a little bit unsettled, but

0:11:06.040 --> 0:11:09.080
<v Speaker 1>there's a great article by by Matt Baggett about this

0:11:09.520 --> 0:11:13.680
<v Speaker 1>and from what we know, he did actually file a

0:11:13.679 --> 0:11:16.719
<v Speaker 1>patent application on one trip to mean, I think it's

0:11:16.760 --> 0:11:19.000
<v Speaker 1>off a methyl trip to mean, because he saw a

0:11:19.000 --> 0:11:22.040
<v Speaker 1>commercial market for it actually as a stimulant, I think,

0:11:22.160 --> 0:11:25.920
<v Speaker 1>for older people. So I don't know that he was

0:11:26.840 --> 0:11:32.160
<v Speaker 1>constitutionally or philosophically against patent applications or filing patents to

0:11:32.200 --> 0:11:35.480
<v Speaker 1>protect work. I think perhaps he just didn't see that

0:11:35.520 --> 0:11:40.520
<v Speaker 1>there was a commercial market for a PSYCHEDELIC. Well, what

0:11:40.559 --> 0:11:42.439
<v Speaker 1>about something like two C B? I mean that's, you know,

0:11:42.480 --> 0:11:46.280
<v Speaker 1>while bigard is one of his major, you know, concoctions. Um.

0:11:46.360 --> 0:11:48.760
<v Speaker 1>But I presume there is no patent and presumably can

0:11:48.800 --> 0:11:50.840
<v Speaker 1>be no patent on two C B, since it's been

0:11:50.840 --> 0:11:53.200
<v Speaker 1>in the public record now correct. So I mean anything

0:11:53.200 --> 0:11:56.800
<v Speaker 1>published in Pikel and Tekel, anything at all. It's the

0:11:56.920 --> 0:12:00.800
<v Speaker 1>chemical structure itself disclosed to the public. That's something that

0:12:01.360 --> 0:12:06.959
<v Speaker 1>can't be patented itself, the structure at least. So perhaps

0:12:06.960 --> 0:12:09.319
<v Speaker 1>we'll get into but but of course, and not to

0:12:09.400 --> 0:12:12.520
<v Speaker 1>jump ahead, but you know there are patent applications filed

0:12:12.559 --> 0:12:15.800
<v Speaker 1>on Psychedelics, even known psychedelics. So the fact that just

0:12:15.920 --> 0:12:20.920
<v Speaker 1>the chemical compound can't receive protection for it alone doesn't

0:12:20.920 --> 0:12:23.560
<v Speaker 1>mean that it can't make part of a claim on

0:12:23.679 --> 0:12:26.880
<v Speaker 1>something else that involves it. So a different method of

0:12:26.920 --> 0:12:30.360
<v Speaker 1>synthesizing it might be able to get patent protection. Sure,

0:12:30.640 --> 0:12:33.160
<v Speaker 1>a method of synthesizing it, maybe even a different form

0:12:33.200 --> 0:12:36.040
<v Speaker 1>of it. So maybe now to jump ahead. But so

0:12:36.520 --> 0:12:39.760
<v Speaker 1>there are some applications that are perhaps the most well

0:12:39.800 --> 0:12:42.840
<v Speaker 1>known in the space that covers psilocybin, some of the

0:12:42.880 --> 0:12:44.760
<v Speaker 1>first to be published, some of the ones that have

0:12:44.880 --> 0:12:48.840
<v Speaker 1>probably received the most conversation around them in controversy, and

0:12:48.920 --> 0:12:53.000
<v Speaker 1>they cover psilocybin in a particular crystalline form. So it's

0:12:53.040 --> 0:12:56.280
<v Speaker 1>not psilocybin, just a chemical structure, but it's the way

0:12:56.280 --> 0:12:59.480
<v Speaker 1>it is when it's part of a for instance, you know,

0:12:59.480 --> 0:13:01.560
<v Speaker 1>a drug dark when it's mixed with an excipient at

0:13:01.600 --> 0:13:04.440
<v Speaker 1>a certain purity and in a particular crystal instructure, as

0:13:04.440 --> 0:13:06.600
<v Speaker 1>somebody would receive it if they got it as a

0:13:06.600 --> 0:13:09.439
<v Speaker 1>prescription medication. So, Graham, why don't we just go directly

0:13:09.480 --> 0:13:11.720
<v Speaker 1>there then? So, I mean the case that most people

0:13:11.760 --> 0:13:14.400
<v Speaker 1>have heard of who follow this even tangentially is the

0:13:14.400 --> 0:13:17.840
<v Speaker 1>case involving compass right, and compass is, you know, one

0:13:17.920 --> 0:13:20.559
<v Speaker 1>of the biggest and most prominent the cycle of companies,

0:13:20.880 --> 0:13:25.240
<v Speaker 1>was founded by the Goldsmith's, George Goldsmith, and his wife,

0:13:25.400 --> 0:13:27.840
<v Speaker 1>and he's taken, you know, a fair bit of Flak

0:13:28.520 --> 0:13:31.400
<v Speaker 1>Um Really, I guess, for two things. One is in

0:13:31.640 --> 0:13:35.640
<v Speaker 1>seeking successfully getting a patent for a particular formulation of

0:13:35.679 --> 0:13:40.920
<v Speaker 1>Psilocybin and then secondly, for you know, being highly ambitious

0:13:41.000 --> 0:13:44.360
<v Speaker 1>aggressive in trying to get patents for all sorts of

0:13:44.360 --> 0:13:49.560
<v Speaker 1>things associated with the administration Um of Psilocybin to treat

0:13:49.840 --> 0:13:52.840
<v Speaker 1>h chronic depression and things like that. So maybe just

0:13:53.000 --> 0:14:01.000
<v Speaker 1>explain to our listeners more about that controversy and it's significant. Yeah,

0:14:01.720 --> 0:14:05.280
<v Speaker 1>and so the controversy on the patents, I think, is

0:14:05.480 --> 0:14:10.120
<v Speaker 1>difficult to view outside of all the ways that it

0:14:10.200 --> 0:14:14.400
<v Speaker 1>is impacted by the broader controversies around compass and compasses

0:14:14.480 --> 0:14:19.760
<v Speaker 1>investors like Peter Thio and their long history. So I

0:14:19.800 --> 0:14:23.120
<v Speaker 1>do think to some degree the controversies on the patents

0:14:23.120 --> 0:14:27.200
<v Speaker 1>are inflected with these broader controversies around how they moved

0:14:27.240 --> 0:14:31.040
<v Speaker 1>from being a nonprofit to a for profit, how they

0:14:31.160 --> 0:14:36.080
<v Speaker 1>obtained information under the guise of what people say saying

0:14:36.080 --> 0:14:38.280
<v Speaker 1>they were at first a nonprofit and speaking with Mak

0:14:38.320 --> 0:14:41.800
<v Speaker 1>any academics who gave them information on on friendly terms

0:14:41.880 --> 0:14:45.600
<v Speaker 1>and then perhaps were tried to be held to nondisclosure agreements,

0:14:45.640 --> 0:14:51.680
<v Speaker 1>and how the company itself at one point allegedly try

0:14:51.760 --> 0:14:54.800
<v Speaker 1>to make it more difficult for its competitors to get

0:14:55.040 --> 0:14:59.000
<v Speaker 1>access to synthetic Solcibin to do research and a number

0:14:59.000 --> 0:15:01.840
<v Speaker 1>of other things. I think that in pact the patent controversies,

0:15:02.120 --> 0:15:08.760
<v Speaker 1>the patent controversies themselves, there's really two types of patents

0:15:08.760 --> 0:15:13.200
<v Speaker 1>that they've pursued. One have been primarily on this psilocybin

0:15:13.760 --> 0:15:17.080
<v Speaker 1>crystal inform, this polymore for polymore of a as it's

0:15:17.520 --> 0:15:20.720
<v Speaker 1>described in their applications, and the other has been an

0:15:20.720 --> 0:15:24.560
<v Speaker 1>application they've filed that published as a pct application that

0:15:24.600 --> 0:15:30.240
<v Speaker 1>did contain all these aspects of the type of psychological

0:15:30.280 --> 0:15:34.040
<v Speaker 1>support a patient would receive and even qualities of the room,

0:15:34.120 --> 0:15:38.400
<v Speaker 1>the soft furniture, the high definition sound system, um. But

0:15:38.480 --> 0:15:44.400
<v Speaker 1>it did cover these interactions with a therapist, like hand

0:15:44.400 --> 0:15:47.560
<v Speaker 1>holding or the therapists putting their hand on the shoulder

0:15:47.600 --> 0:15:51.120
<v Speaker 1>of the patient and things. That seems clearly to be

0:15:52.440 --> 0:15:56.760
<v Speaker 1>part of what would expect perhaps in psilocybin therapy and

0:15:57.040 --> 0:15:59.560
<v Speaker 1>part of what one would expect perhaps not to be

0:15:59.600 --> 0:16:02.080
<v Speaker 1>things like be protected by a patent. In any event,

0:16:02.280 --> 0:16:03.840
<v Speaker 1>I mean it sounds like total huts, but I mean

0:16:03.880 --> 0:16:06.440
<v Speaker 1>the hand holding, our soft furniture or their sound stuff.

0:16:06.560 --> 0:16:09.320
<v Speaker 1>I mean that's so inherent to the experience that why

0:16:09.320 --> 0:16:11.560
<v Speaker 1>would they even think to include that stuff in the

0:16:11.600 --> 0:16:14.400
<v Speaker 1>first place? Is it just a broader notion that we're

0:16:14.400 --> 0:16:16.320
<v Speaker 1>getting a patent. You sort of throw everything against the

0:16:16.320 --> 0:16:19.360
<v Speaker 1>wall and see what sticks or or isn't there an

0:16:19.360 --> 0:16:22.480
<v Speaker 1>element of embarrassment about going that far? Yeah, yeah, I

0:16:22.480 --> 0:16:25.840
<v Speaker 1>mean I am actually surprised of anything and I don't

0:16:25.880 --> 0:16:28.560
<v Speaker 1>know what was encompasses minds when they filed this. So

0:16:28.560 --> 0:16:32.480
<v Speaker 1>I can only sort of assume, based on my presumption

0:16:32.520 --> 0:16:36.360
<v Speaker 1>of how most Patent Attorneys Act, I would be surprised

0:16:36.400 --> 0:16:40.280
<v Speaker 1>that they didn't spend the effort to call through their

0:16:40.320 --> 0:16:42.640
<v Speaker 1>patent a little bit or that that claims to see

0:16:43.000 --> 0:16:46.640
<v Speaker 1>what might raise these controversies. But it is fairly standard

0:16:46.640 --> 0:16:51.120
<v Speaker 1>practice when filing a PCT application to include often several

0:16:51.160 --> 0:16:55.560
<v Speaker 1>hundred claims and there's no additional charges for those claims.

0:16:55.600 --> 0:16:58.920
<v Speaker 1>Like there is a national examination and there's there's no

0:16:59.000 --> 0:17:03.320
<v Speaker 1>real downside to shooting them and so oftentimes everything that's

0:17:03.400 --> 0:17:06.880
<v Speaker 1>described in an application to some degree will make its

0:17:06.920 --> 0:17:09.199
<v Speaker 1>way into a claim and there may not be in

0:17:09.240 --> 0:17:13.280
<v Speaker 1>the end any real desire to pursue those things. Perhaps

0:17:13.320 --> 0:17:16.520
<v Speaker 1>the company wants to get an opinion. So actually, as

0:17:16.800 --> 0:17:20.040
<v Speaker 1>part of the PCT process, the applicant will get a

0:17:20.040 --> 0:17:23.600
<v Speaker 1>preliminary opinion from a PCT examiner. You're using an acronym.

0:17:23.640 --> 0:17:28.639
<v Speaker 1>There was it pct. So pct is a acronym that

0:17:28.680 --> 0:17:31.800
<v Speaker 1>stands for the Patent Cooperation Treaty. So it's a treaty

0:17:31.800 --> 0:17:35.040
<v Speaker 1>that has now a hundred and fifties seven, I think, members.

0:17:35.760 --> 0:17:40.040
<v Speaker 1>It's basically a treaty that allows anybody to file a

0:17:40.160 --> 0:17:43.800
<v Speaker 1>single application, that's the PCT application, and then have up

0:17:43.840 --> 0:17:47.440
<v Speaker 1>to thirty months from the earliest filing date to decide

0:17:47.440 --> 0:17:49.320
<v Speaker 1>whether to enter any of those a hundred and fifty

0:17:49.359 --> 0:17:53.120
<v Speaker 1>seven member states individually. And so the benefit of doing

0:17:53.160 --> 0:17:57.080
<v Speaker 1>that is if you want to file and multiple applications,

0:17:57.680 --> 0:17:59.720
<v Speaker 1>you know that's going to take a lot of expense

0:17:59.760 --> 0:18:03.320
<v Speaker 1>to to translate your documents, you'll have to pay lawyers

0:18:03.440 --> 0:18:06.119
<v Speaker 1>to be your agent and each those different jurisdictions, and

0:18:06.160 --> 0:18:07.440
<v Speaker 1>so if you had to do that all at once,

0:18:07.840 --> 0:18:10.160
<v Speaker 1>but how it would be a lot of upfront costs

0:18:10.320 --> 0:18:14.000
<v Speaker 1>which in the end you may decide you don't even

0:18:14.040 --> 0:18:16.320
<v Speaker 1>want to pursue it, depending on how your drug development

0:18:16.320 --> 0:18:18.880
<v Speaker 1>and your research is going. So this sort of provides

0:18:18.880 --> 0:18:22.639
<v Speaker 1>an ability to file a single application, get that preliminary

0:18:22.640 --> 0:18:25.359
<v Speaker 1>opinion and hold off on some of those costs to

0:18:25.760 --> 0:18:28.560
<v Speaker 1>see if, down the road and in thirty months. However,

0:18:28.600 --> 0:18:32.440
<v Speaker 1>it takes whether it's even worth filing in those different jurisdictions.

0:18:32.440 --> 0:18:36.280
<v Speaker 1>So are most patent applications in the US simultaneously PCT applications,

0:18:36.359 --> 0:18:38.240
<v Speaker 1>or do people make a judgment and it's only apply

0:18:38.280 --> 0:18:40.600
<v Speaker 1>in a few cases? Sometimes people, if they want to

0:18:40.640 --> 0:18:44.080
<v Speaker 1>accelerate their patent grant, they might file both in the

0:18:44.160 --> 0:18:48.760
<v Speaker 1>US and the PCT simultaneously, or sometimes will enter us

0:18:48.880 --> 0:18:52.159
<v Speaker 1>or another country early and not wait the full thirty months.

0:18:52.960 --> 0:18:55.960
<v Speaker 1>It really depends on the technology. So you can imagine

0:18:56.320 --> 0:19:00.160
<v Speaker 1>in a fast moving technology like the invention that has

0:19:00.200 --> 0:19:03.160
<v Speaker 1>to do with your smartphone, somebody might want to get

0:19:03.160 --> 0:19:07.399
<v Speaker 1>the patent granted as quickly as possible because the value

0:19:07.440 --> 0:19:10.119
<v Speaker 1>that application and the value of that invention might not

0:19:10.160 --> 0:19:13.720
<v Speaker 1>even exist five years from now. With something like drug discovery,

0:19:13.840 --> 0:19:15.760
<v Speaker 1>you might not have a drug on the market for

0:19:15.800 --> 0:19:17.600
<v Speaker 1>seven years or eight years or longer, and so you

0:19:17.640 --> 0:19:21.240
<v Speaker 1>don't really need to worry about having something that you

0:19:21.280 --> 0:19:27.040
<v Speaker 1>can hold against a potentially infringing competitor for for much longer. Now.

0:19:27.080 --> 0:19:29.639
<v Speaker 1>If if a company that did not have some of

0:19:29.680 --> 0:19:33.520
<v Speaker 1>those negative associations you describe about compass in terms of

0:19:33.520 --> 0:19:36.800
<v Speaker 1>their investors, in terms of, you know, having first been

0:19:36.840 --> 0:19:39.320
<v Speaker 1>a nonprofit and taking advantage of that to give them

0:19:39.320 --> 0:19:41.760
<v Speaker 1>an edge up as they became a for profit company.

0:19:41.840 --> 0:19:44.199
<v Speaker 1>Would there have been as much controversy you think about

0:19:44.359 --> 0:19:46.960
<v Speaker 1>them seeking and getting a patent for this other way

0:19:47.000 --> 0:19:49.920
<v Speaker 1>of Synthesizing Psilocybin? I think there are probably some other

0:19:49.960 --> 0:19:54.720
<v Speaker 1>reasons besides just those you mentioned about the other ethics

0:19:54.760 --> 0:19:57.480
<v Speaker 1>perhaps of the company. I think one of them may

0:19:57.520 --> 0:19:59.560
<v Speaker 1>just have to do that they were really the first

0:19:59.600 --> 0:20:04.840
<v Speaker 1>company that had a published psychedelics related application, so most

0:20:04.840 --> 0:20:07.520
<v Speaker 1>of the attention when it came was just directed to them,

0:20:07.600 --> 0:20:11.879
<v Speaker 1>as people were surprised to see something filed on a psychedelic.

0:20:12.160 --> 0:20:13.800
<v Speaker 1>I think another ask to do with the fact that

0:20:13.840 --> 0:20:18.800
<v Speaker 1>it's on Psilocybin and so many of the patent applications

0:20:18.840 --> 0:20:22.200
<v Speaker 1>on new chemical quantities, on on different types of psychedelics.

0:20:22.240 --> 0:20:25.959
<v Speaker 1>Perhaps had Sasha Shulgun filed them on to Seeb when

0:20:26.040 --> 0:20:29.320
<v Speaker 1>he first invented it, or another psychedelic that had never

0:20:29.359 --> 0:20:33.640
<v Speaker 1>been before known, those might have less, less controversy. With

0:20:33.840 --> 0:20:36.879
<v Speaker 1>psilocybin in particular, we know, of course, not only was

0:20:36.920 --> 0:20:41.000
<v Speaker 1>it discovered, I suppose, by the West with with Albert Hoffman,

0:20:41.040 --> 0:20:44.639
<v Speaker 1>and then patented, but it's been used in traditional and

0:20:44.880 --> 0:20:49.600
<v Speaker 1>indigenous ceremonies and uses for centuries or millennium even, and

0:20:49.640 --> 0:20:57.120
<v Speaker 1>so those aspects also caused another layer of controversy. We'll

0:20:57.119 --> 0:21:14.200
<v Speaker 1>be talking more after we hear this ad when people

0:21:14.240 --> 0:21:16.080
<v Speaker 1>talk about what are the first substances that are going

0:21:16.119 --> 0:21:19.400
<v Speaker 1>to be approved for treating uh, you know, different types

0:21:19.440 --> 0:21:22.119
<v Speaker 1>of mental illness, people topically typically talk about m d

0:21:22.280 --> 0:21:25.119
<v Speaker 1>m a and the process that the organization maps is

0:21:25.160 --> 0:21:27.520
<v Speaker 1>pursuing to get approved by the FD A, hopefully later

0:21:27.560 --> 0:21:29.679
<v Speaker 1>this year next year. And the other one is the

0:21:29.720 --> 0:21:34.480
<v Speaker 1>process being pursued by compass to get psilocybin approved for treating,

0:21:34.640 --> 0:21:38.480
<v Speaker 1>I think, uh, intractable depression, and the argument by the

0:21:38.520 --> 0:21:41.159
<v Speaker 1>Goldsmiths and others is that if we did not have

0:21:41.240 --> 0:21:46.080
<v Speaker 1>a chance to patent this synthetics Um Psilocybin, then we,

0:21:46.200 --> 0:21:48.480
<v Speaker 1>quite frankly, could not raise the money to go through

0:21:48.480 --> 0:21:52.480
<v Speaker 1>the entire approval process required to get psilocybin approved for

0:21:52.640 --> 0:21:56.159
<v Speaker 1>treatment in the first place. So what's the response to

0:21:56.240 --> 0:22:00.080
<v Speaker 1>their argument? Well, that is definitely the argument that is

0:22:00.560 --> 0:22:03.840
<v Speaker 1>always used by pharmaceutical companies and a big part of

0:22:03.880 --> 0:22:07.240
<v Speaker 1>the controversy around compass also is the fact that there

0:22:07.280 --> 0:22:11.760
<v Speaker 1>were other companies also pursuing psilocybin, like you SONA or

0:22:11.840 --> 0:22:16.000
<v Speaker 1>clinical development around the same time, and there are concerns

0:22:16.040 --> 0:22:20.240
<v Speaker 1>that by filing these patent applications, compass may preclude others

0:22:20.440 --> 0:22:22.560
<v Speaker 1>from even continuing to do the work that they may

0:22:22.600 --> 0:22:28.800
<v Speaker 1>have started the forehand, and precluding other companies from their

0:22:28.840 --> 0:22:32.919
<v Speaker 1>work and bringing psilocybin also to patients. And so I

0:22:32.960 --> 0:22:36.880
<v Speaker 1>think we can also perhaps look at maps, as you mentioned,

0:22:36.920 --> 0:22:40.600
<v Speaker 1>as alternative models to being able to bring a drug

0:22:40.920 --> 0:22:44.399
<v Speaker 1>through the FDA approval process without patents, although maps is

0:22:44.440 --> 0:22:49.760
<v Speaker 1>also relying on something called data exclusivity. So data exclusivity

0:22:49.800 --> 0:22:54.080
<v Speaker 1>is a regulatory benefit that when a company is first

0:22:54.240 --> 0:22:58.920
<v Speaker 1>to obtain regulatory approval for a compound before anyone else

0:22:59.000 --> 0:23:01.280
<v Speaker 1>on that compound, as maps would be with M D

0:23:01.400 --> 0:23:05.240
<v Speaker 1>M A, that company has given five years or perhaps longer,

0:23:06.240 --> 0:23:11.800
<v Speaker 1>to be the exclusive company to sell that compound before

0:23:11.840 --> 0:23:16.000
<v Speaker 1>others can rely on its regulatory data to also seek approval.

0:23:16.680 --> 0:23:19.560
<v Speaker 1>And so that does give maps a period of time

0:23:19.640 --> 0:23:23.600
<v Speaker 1>which will be at least five years. Two gain back

0:23:23.680 --> 0:23:27.359
<v Speaker 1>the type of profits that are argued to be necessary

0:23:27.440 --> 0:23:31.119
<v Speaker 1>to bring the drug through drug discovery, although of course

0:23:31.200 --> 0:23:35.320
<v Speaker 1>maps also relies on philanthropic funding to have gotten the

0:23:35.359 --> 0:23:38.200
<v Speaker 1>drug to that point, to be able to get that

0:23:38.280 --> 0:23:41.240
<v Speaker 1>data exclusivity. I've had Rick Doublin on and so you know,

0:23:41.280 --> 0:23:43.879
<v Speaker 1>obviously we look at with the maps model where they

0:23:43.920 --> 0:23:46.240
<v Speaker 1>set up to nonprofits that sets up what's called a

0:23:46.280 --> 0:23:49.719
<v Speaker 1>public benefit corporation in order to market M D M

0:23:49.760 --> 0:23:51.800
<v Speaker 1>A and M D m a treatment once it's approved

0:23:51.800 --> 0:23:54.359
<v Speaker 1>by the F D A, with all the profits going

0:23:54.440 --> 0:23:57.639
<v Speaker 1>back into maps, and then maps pouring all those profits

0:23:57.680 --> 0:24:02.560
<v Speaker 1>into further, you know, good cluset right, psychedelics, uh research

0:24:02.600 --> 0:24:05.600
<v Speaker 1>and even into broader drug policy reform. I don't know

0:24:05.600 --> 0:24:07.520
<v Speaker 1>if it's an optimal model, but we see it as

0:24:07.520 --> 0:24:10.360
<v Speaker 1>one of the best models out there. Conversely, we look

0:24:10.400 --> 0:24:12.560
<v Speaker 1>at a thing like compass, which is essentially a for

0:24:12.800 --> 0:24:16.879
<v Speaker 1>profit company, you know, with obligations to its shareholders and

0:24:16.920 --> 0:24:20.240
<v Speaker 1>produce your obligations there. Um See, you know that that,

0:24:20.359 --> 0:24:22.920
<v Speaker 1>even though it's going to be producing something that's valuable

0:24:23.080 --> 0:24:26.760
<v Speaker 1>for humankind in terms of Psilocybin being used to treat

0:24:27.119 --> 0:24:30.920
<v Speaker 1>intractable depression, ultimately there's a bottom line profit. Saying. Now

0:24:30.920 --> 0:24:33.359
<v Speaker 1>there's another entity, activists in all of this. There's an

0:24:33.440 --> 0:24:37.000
<v Speaker 1>or of nonprofit called freedom to operate, which was started

0:24:37.040 --> 0:24:40.080
<v Speaker 1>by one of the major philanthropists in the psychelics area,

0:24:40.359 --> 0:24:43.800
<v Speaker 1>carry turnbull, and freedom to operate was really set up

0:24:43.840 --> 0:24:47.560
<v Speaker 1>to kind of prevent for profit companies from taking advantage

0:24:47.720 --> 0:24:51.160
<v Speaker 1>and using their finance and power to block others from

0:24:51.160 --> 0:24:54.800
<v Speaker 1>getting involved. And ultimately they spent a million dollars or

0:24:54.800 --> 0:24:58.760
<v Speaker 1>more to challenge compasses effort and ultimately they failed. Compass

0:24:58.800 --> 0:25:01.520
<v Speaker 1>prevailed and I'm sure is did you think that freedom

0:25:01.560 --> 0:25:04.840
<v Speaker 1>to operate was going to succeed, Um, and therefore surprised

0:25:04.880 --> 0:25:07.560
<v Speaker 1>if they were not successful? Or why do you think

0:25:07.600 --> 0:25:11.320
<v Speaker 1>compass did prevail in the end? Well, so I wasn't

0:25:11.640 --> 0:25:15.119
<v Speaker 1>terribly surprised. It's, I think, a result more of just

0:25:15.240 --> 0:25:19.600
<v Speaker 1>the nature of patent law. The compass has quite narrow claims,

0:25:20.000 --> 0:25:22.879
<v Speaker 1>even though they've been often described as really blocking the field.

0:25:23.280 --> 0:25:27.199
<v Speaker 1>Quite narrow claims on this specific polymorph and there they

0:25:27.240 --> 0:25:30.240
<v Speaker 1>are drafted in such a way that it's quite difficult

0:25:30.280 --> 0:25:36.240
<v Speaker 1>to have evidence to show that anything before there application

0:25:36.320 --> 0:25:40.160
<v Speaker 1>was filed would be the same as what they're covering Um,

0:25:40.400 --> 0:25:42.160
<v Speaker 1>and so that's, you know, sort of just a trick

0:25:42.240 --> 0:25:45.640
<v Speaker 1>of their patent drafting and a trick of the way

0:25:45.680 --> 0:25:50.320
<v Speaker 1>that the patent system itself operates, and so I don't

0:25:50.320 --> 0:25:53.879
<v Speaker 1>think I was surprised at the outcome of the case. But,

0:25:54.400 --> 0:25:56.480
<v Speaker 1>you know, I certainly do see the you know, the

0:25:56.560 --> 0:26:00.600
<v Speaker 1>concerns around the fact that there, of course, we're forms

0:26:00.600 --> 0:26:03.960
<v Speaker 1>of synthetic Paul cybin before and there may be other

0:26:04.000 --> 0:26:07.800
<v Speaker 1>forms of synthetic pulcybin that, even if they had been

0:26:08.280 --> 0:26:12.360
<v Speaker 1>produced before and in use before, they may now infringe

0:26:12.800 --> 0:26:16.080
<v Speaker 1>compasses claims and so to the degree they would be

0:26:16.080 --> 0:26:19.960
<v Speaker 1>able to keep a competitor from being able to market

0:26:20.000 --> 0:26:23.360
<v Speaker 1>their own sulcybin products. I do see that that's a concern.

0:26:23.560 --> 0:26:25.200
<v Speaker 1>So Great. Let me circle around in it from a

0:26:25.200 --> 0:26:27.399
<v Speaker 1>different angle on this in this case, you know, I

0:26:27.560 --> 0:26:32.560
<v Speaker 1>had a while back Leonard Picard on psychoactive and as

0:26:32.600 --> 0:26:34.959
<v Speaker 1>many of our listeners know, you know he is regarded

0:26:35.000 --> 0:26:38.960
<v Speaker 1>as one of the great underground chemists UH and produces LSD.

0:26:39.040 --> 0:26:41.280
<v Speaker 1>In the late twentieth century he spent a couple of

0:26:41.320 --> 0:26:43.879
<v Speaker 1>decades in prison and fortunately got out. But when he

0:26:43.920 --> 0:26:47.200
<v Speaker 1>speaks about the underground, the Brotherhood of underground chemists and

0:26:47.240 --> 0:26:51.520
<v Speaker 1>he and others creating you know, they're unique types of LSD.

0:26:51.760 --> 0:26:55.080
<v Speaker 1>You know, were these things that potentially could have been

0:26:55.240 --> 0:26:59.280
<v Speaker 1>patented if these guys had wanted to go through that process,

0:26:59.400 --> 0:27:02.720
<v Speaker 1>notwithstanding it's illegality, were they likely doing things that were

0:27:02.720 --> 0:27:05.320
<v Speaker 1>sufficiently unique in terms of the way that they were

0:27:05.640 --> 0:27:09.119
<v Speaker 1>synthesizing or making the lst that would have been patentable? Well,

0:27:09.119 --> 0:27:11.040
<v Speaker 1>that's that's a really good question. I mean how unique

0:27:11.080 --> 0:27:12.879
<v Speaker 1>they were. I guess I'd have to talk to Leonard

0:27:13.119 --> 0:27:17.119
<v Speaker 1>to understand the, you know, the steps of the process

0:27:17.119 --> 0:27:21.560
<v Speaker 1>that allegedly he was pursuing, and certainly I don't I

0:27:21.560 --> 0:27:25.240
<v Speaker 1>don't know enough about the chemistry to understand if it

0:27:25.320 --> 0:27:29.200
<v Speaker 1>was something that was patentable. Um, in terms of whether

0:27:29.320 --> 0:27:32.600
<v Speaker 1>the patent office might grant a patent on it, I

0:27:32.640 --> 0:27:36.560
<v Speaker 1>think because of the fact that many of these processes

0:27:36.840 --> 0:27:41.240
<v Speaker 1>were not published and we're not included in any prior patents,

0:27:41.480 --> 0:27:44.960
<v Speaker 1>the patent office generally, I think it's perhaps safe to say,

0:27:45.320 --> 0:27:47.119
<v Speaker 1>could have granted patents on them, and so there is

0:27:47.119 --> 0:27:50.879
<v Speaker 1>a bit of a disconnect there in terms of a

0:27:50.920 --> 0:27:53.000
<v Speaker 1>patent to be granted has to be something that's novel

0:27:53.240 --> 0:27:56.680
<v Speaker 1>and inventive, but the patent office to determine whether something

0:27:56.760 --> 0:28:01.119
<v Speaker 1>is novel and inventive really just looks at higher literature

0:28:01.720 --> 0:28:05.040
<v Speaker 1>and some of the peer of viewed literature and some

0:28:05.080 --> 0:28:08.320
<v Speaker 1>of the places that are more obvious to do research,

0:28:08.840 --> 0:28:11.439
<v Speaker 1>but it certainly doesn't look to see what people are

0:28:11.440 --> 0:28:13.720
<v Speaker 1>doing in the underground and even today might not look

0:28:13.760 --> 0:28:16.160
<v Speaker 1>at things that one might see as obvious, like looking

0:28:16.200 --> 0:28:20.240
<v Speaker 1>on Uh errowit or blue light or a forum, UM,

0:28:20.240 --> 0:28:23.760
<v Speaker 1>looking on Reddit, even doing a google search. M You know,

0:28:23.800 --> 0:28:25.919
<v Speaker 1>actually there there's a case. I mean you used a

0:28:26.040 --> 0:28:29.320
<v Speaker 1>term of art in the patent law field, prior art,

0:28:30.000 --> 0:28:33.719
<v Speaker 1>and and I've oftentimes read about the infamous example of

0:28:33.760 --> 0:28:37.359
<v Speaker 1>the D Mt Vate Pen uh and it sounds like

0:28:37.400 --> 0:28:40.720
<v Speaker 1>that's a pretty good example of one of the major problems,

0:28:40.800 --> 0:28:43.480
<v Speaker 1>not just in the psycholical area but the broader pattern area,

0:28:43.840 --> 0:28:46.760
<v Speaker 1>that we now have a federal pattern office which has

0:28:46.800 --> 0:28:49.720
<v Speaker 1>existed for two centuries. I mean pattern law is in

0:28:49.800 --> 0:28:54.360
<v Speaker 1>the U S constitution, but where it's overstaffed and undertrained.

0:28:54.440 --> 0:28:56.600
<v Speaker 1>So just tell our listeners a little bit more about

0:28:56.640 --> 0:28:58.800
<v Speaker 1>that d m t U Vay pen and why it

0:28:58.920 --> 0:29:00.800
<v Speaker 1>stands out there is an the apple and what's wrong

0:29:00.800 --> 0:29:03.120
<v Speaker 1>with the system. Yeah, I mean that example I used

0:29:03.320 --> 0:29:06.080
<v Speaker 1>generally just because it's it's very easy to see how

0:29:06.600 --> 0:29:09.800
<v Speaker 1>the patent office in this case just completely missed the

0:29:09.800 --> 0:29:14.560
<v Speaker 1>prior art and it's a really good example using it again.

0:29:14.640 --> 0:29:18.280
<v Speaker 1>So the prior art is a term of art. I suppose.

0:29:18.520 --> 0:29:22.040
<v Speaker 1>The prior just means anything that's public before the date

0:29:22.080 --> 0:29:25.440
<v Speaker 1>that the patent application was filed. The main part of

0:29:25.440 --> 0:29:28.320
<v Speaker 1>the patent examination process is just for the patent examiner

0:29:28.360 --> 0:29:31.120
<v Speaker 1>to look at the application and in particular, the claims

0:29:31.120 --> 0:29:33.400
<v Speaker 1>of the application. So the claims are what the applicant

0:29:33.560 --> 0:29:36.680
<v Speaker 1>rights to say this is what I should own, and

0:29:36.760 --> 0:29:40.280
<v Speaker 1>it compares those claims to what's in what's called the

0:29:40.320 --> 0:29:42.920
<v Speaker 1>prior art, which just means everything that's public before the

0:29:43.160 --> 0:29:46.320
<v Speaker 1>patent was filed, so everything that was basically in the

0:29:46.360 --> 0:29:50.000
<v Speaker 1>public domain. So, for instance, was something like a vape pen.

0:29:50.520 --> 0:29:53.960
<v Speaker 1>The patent applicant will draft a claim that will say

0:29:54.000 --> 0:29:58.120
<v Speaker 1>a you know, a device for vaporization that contains a

0:29:59.280 --> 0:30:02.920
<v Speaker 1>chamber with a liquid for vaporization, with a chemical compound

0:30:03.000 --> 0:30:06.120
<v Speaker 1>like D mt, and then the patent examiner will take

0:30:06.160 --> 0:30:08.600
<v Speaker 1>that claim and say, well, has anybody else ever done

0:30:08.640 --> 0:30:10.920
<v Speaker 1>this or describe this before, and then it will do

0:30:10.960 --> 0:30:13.760
<v Speaker 1>a search and then it will see if somebody has

0:30:13.880 --> 0:30:16.160
<v Speaker 1>if somebody has and will project the claim and then

0:30:16.160 --> 0:30:18.760
<v Speaker 1>the applicant will come back and say, well, but they

0:30:18.760 --> 0:30:20.840
<v Speaker 1>didn't do it quite like this or the way I'm

0:30:20.840 --> 0:30:24.160
<v Speaker 1>doing it is a little bit narrower, or they'll say no,

0:30:24.240 --> 0:30:27.520
<v Speaker 1>you're you're misreading with the prior art says and actually

0:30:27.520 --> 0:30:31.560
<v Speaker 1>it says something different. Um and the patent examination process

0:30:31.760 --> 0:30:35.440
<v Speaker 1>might take four or five years or longer, with three

0:30:35.480 --> 0:30:37.600
<v Speaker 1>or four or five different times going back and forth

0:30:37.640 --> 0:30:41.280
<v Speaker 1>in writing or sometimes with phone interviews between the Examiner

0:30:41.320 --> 0:30:44.239
<v Speaker 1>and the applicant to decide what's in the prior art

0:30:44.320 --> 0:30:47.320
<v Speaker 1>and what's being claimed and to try to narrow the

0:30:47.320 --> 0:30:50.720
<v Speaker 1>claim so nothing in the claim is covered or covers

0:30:50.800 --> 0:30:54.120
<v Speaker 1>what's in the prior art with this d m t vapen.

0:30:54.520 --> 0:31:00.400
<v Speaker 1>So the application covered basically D M T vapens. They're

0:31:00.480 --> 0:31:04.680
<v Speaker 1>very broadest had figures which were pictures basically of, you know,

0:31:04.680 --> 0:31:07.600
<v Speaker 1>what you would imagine a d m t vapen looks like,

0:31:07.640 --> 0:31:10.320
<v Speaker 1>the same way you know a cannabis vape looks like

0:31:10.320 --> 0:31:14.000
<v Speaker 1>the kind you can buy the dispensary. Um and the

0:31:14.240 --> 0:31:17.560
<v Speaker 1>patent examiner did a search and it looked at prior

0:31:17.600 --> 0:31:20.680
<v Speaker 1>patent applications and then it did a search in a

0:31:20.840 --> 0:31:27.400
<v Speaker 1>particular database of chemical abstracts from the just scientific literature

0:31:27.960 --> 0:31:30.880
<v Speaker 1>for less than seven minutes, because everything is on the record.

0:31:30.920 --> 0:31:33.520
<v Speaker 1>So you can see the search terms they use, you

0:31:33.560 --> 0:31:35.600
<v Speaker 1>can see how much time they spent, you can see

0:31:35.600 --> 0:31:39.080
<v Speaker 1>the databases. They looked in Um and they searched for

0:31:39.160 --> 0:31:41.800
<v Speaker 1>a few terms like dimethyl trip to mean, but they

0:31:41.800 --> 0:31:45.200
<v Speaker 1>didn't search for d m t, the abbreviate just to letters.

0:31:45.560 --> 0:31:48.080
<v Speaker 1>They didn't search for Vapen, they didn't search for Google

0:31:48.560 --> 0:31:51.520
<v Speaker 1>and because of that they missed the fact that the

0:31:52.680 --> 0:31:54.920
<v Speaker 1>few months prior to the application being filed there was

0:31:54.960 --> 0:31:57.080
<v Speaker 1>a whole double blind article on d m D v

0:31:57.080 --> 0:31:59.680
<v Speaker 1>Apens with many pictures. It looked just like the pictures

0:31:59.680 --> 0:32:02.560
<v Speaker 1>in the path an application. UH, several years before that

0:32:02.600 --> 0:32:06.560
<v Speaker 1>there was an article by somebody, Lester Black, who wrote

0:32:06.880 --> 0:32:09.080
<v Speaker 1>all about D M T v APENS and actually wrote

0:32:09.080 --> 0:32:11.320
<v Speaker 1>about how he receives some copies of D M T

0:32:11.440 --> 0:32:15.080
<v Speaker 1>v APENS and describes him in the article Um. Coincidentally,

0:32:15.160 --> 0:32:16.880
<v Speaker 1>D M T v APENS. That actually, I believe, came

0:32:16.920 --> 0:32:20.000
<v Speaker 1>from David Heldre, who, David Heldreth, has talked about this.

0:32:20.280 --> 0:32:23.200
<v Speaker 1>So I don't think I'm revealing anything offered controversial. Actually

0:32:23.200 --> 0:32:25.960
<v Speaker 1>say tell our audience who David Heldreth. So David Heldreth

0:32:26.040 --> 0:32:29.120
<v Speaker 1>is the CEO of Pantasy Plant Sciences who he mentioned,

0:32:29.120 --> 0:32:31.920
<v Speaker 1>who was the sort of thorn in the d a side,

0:32:32.320 --> 0:32:34.000
<v Speaker 1>who may have been part of the reason why the

0:32:34.080 --> 0:32:36.400
<v Speaker 1>d a had been thinking about these particular trip to

0:32:36.440 --> 0:32:39.320
<v Speaker 1>means when they decided to schedule them. Um, just a

0:32:39.560 --> 0:32:41.920
<v Speaker 1>sort of small world coincidence in terms of getting back

0:32:41.920 --> 0:32:44.200
<v Speaker 1>to the DM DV apens. But in any event, because

0:32:44.280 --> 0:32:47.680
<v Speaker 1>the patent examiner didn't do a google search, didn't search

0:32:47.720 --> 0:32:50.600
<v Speaker 1>for vapen or for D M T, they decided that

0:32:50.640 --> 0:32:55.080
<v Speaker 1>this was a novel and Inventive Uh invention and they

0:32:55.200 --> 0:32:59.040
<v Speaker 1>granted it patent on it, and the patent covers any

0:32:59.120 --> 0:33:01.440
<v Speaker 1>d m t vapen that you would see and can

0:33:01.480 --> 0:33:03.600
<v Speaker 1>that pattern that will be reversed. I mean now that

0:33:03.640 --> 0:33:06.880
<v Speaker 1>there their mistakes are become so publicly known, it could

0:33:06.960 --> 0:33:13.600
<v Speaker 1>be Um, the you know the the type of effort

0:33:13.640 --> 0:33:16.760
<v Speaker 1>it might take, but it hasn't been. No. So somebody

0:33:16.760 --> 0:33:19.640
<v Speaker 1>could do what for him to operate did as you mentioned?

0:33:19.640 --> 0:33:21.240
<v Speaker 1>I don't think it. In this instance. It would costs

0:33:21.280 --> 0:33:23.840
<v Speaker 1>a million dollars, but it is quite expensive so it's

0:33:24.080 --> 0:33:27.719
<v Speaker 1>over fifty dollars just in filing fees to the patent

0:33:27.720 --> 0:33:32.160
<v Speaker 1>office two challenge a patent after it's been granted, Um.

0:33:32.280 --> 0:33:34.440
<v Speaker 1>And of course that's before you even pay for for

0:33:34.520 --> 0:33:36.840
<v Speaker 1>lawyers and in many instances you probably have to pay

0:33:36.880 --> 0:33:40.560
<v Speaker 1>for an expert to submit an affidavit Um and gather

0:33:40.640 --> 0:33:43.840
<v Speaker 1>other factual information. So it's, you know, a bit prohibitive

0:33:44.280 --> 0:33:47.800
<v Speaker 1>to be able to challenge patents after they've been been granted.

0:33:47.880 --> 0:33:51.120
<v Speaker 1>And so you know, the D M T v APEN has,

0:33:51.400 --> 0:33:53.880
<v Speaker 1>you know, it's not not necessarily the example of the

0:33:53.920 --> 0:33:56.840
<v Speaker 1>most valuable patent that's out there, but it's a an

0:33:56.840 --> 0:33:59.200
<v Speaker 1>easy example to see the way that the patent office

0:33:59.240 --> 0:34:01.640
<v Speaker 1>can miss things and in this way of missing things

0:34:01.720 --> 0:34:04.640
<v Speaker 1>because of, as you mentioned, that the Patent Examiners are

0:34:04.960 --> 0:34:09.439
<v Speaker 1>typically overworked. Um. There's actually a bill pending right now

0:34:09.520 --> 0:34:12.600
<v Speaker 1>by by two senators, Leahy and until us, to try

0:34:12.600 --> 0:34:15.439
<v Speaker 1>to give pattent examiners more time. They don't always spend

0:34:15.480 --> 0:34:18.360
<v Speaker 1>as little as seven minutes, but they don't generally spend

0:34:18.400 --> 0:34:21.080
<v Speaker 1>all that much time and not enough time because of

0:34:21.080 --> 0:34:25.200
<v Speaker 1>the way they're rewarded up for just moving quickly through applications,

0:34:25.239 --> 0:34:28.759
<v Speaker 1>and so this means that many patents get granted and

0:34:29.640 --> 0:34:32.800
<v Speaker 1>many of those granted patents can end up being asserted

0:34:32.840 --> 0:34:35.920
<v Speaker 1>against companies who could have been doing the same thing

0:34:35.920 --> 0:34:37.680
<v Speaker 1>they were doing even before the patent was filed, and

0:34:37.920 --> 0:34:42.440
<v Speaker 1>so this is often kind of wasteful litigation that it's

0:34:42.680 --> 0:34:45.319
<v Speaker 1>taking away from real innovation. One thing also, I mean

0:34:45.360 --> 0:34:47.960
<v Speaker 1>I know you worked in, Uh did a fair bit

0:34:47.960 --> 0:34:50.640
<v Speaker 1>of work in the area of marijuana law and patents

0:34:50.800 --> 0:34:54.040
<v Speaker 1>before you jump more fully into the psychedelics area. And

0:34:54.080 --> 0:34:56.920
<v Speaker 1>I saw that one of the CO founder of Compass,

0:34:57.000 --> 0:35:00.799
<v Speaker 1>George Goldsmith, was quoted as saying that when he it started,

0:35:01.239 --> 0:35:05.440
<v Speaker 1>one of his models, his role models, was GW pharmaceutical,

0:35:05.880 --> 0:35:08.160
<v Speaker 1>you know, the UK firm which I think was the

0:35:08.200 --> 0:35:12.400
<v Speaker 1>first to get approval and get a patent for its

0:35:12.520 --> 0:35:15.960
<v Speaker 1>Um you know, it's it's version of medical marijuana. So

0:35:16.080 --> 0:35:18.640
<v Speaker 1>can you say a little something? Why would why would

0:35:18.680 --> 0:35:21.120
<v Speaker 1>George Goldsmith, ahead of compass, have looked to g double

0:35:21.200 --> 0:35:26.040
<v Speaker 1>pharmaceutical and what was the significance in the marijuana field? Um, well,

0:35:26.440 --> 0:35:28.200
<v Speaker 1>it's a good question and actually I should say I

0:35:28.200 --> 0:35:31.000
<v Speaker 1>think even my start to a large degree was because

0:35:31.040 --> 0:35:33.680
<v Speaker 1>of what G W Farma was doing in that a

0:35:33.719 --> 0:35:38.200
<v Speaker 1>lot of my early clients in the cannabis days before

0:35:38.239 --> 0:35:40.759
<v Speaker 1>I started working in Psychedelics, was because there are many

0:35:40.760 --> 0:35:43.360
<v Speaker 1>companies that were looking at what Gw was doing and

0:35:43.360 --> 0:35:46.080
<v Speaker 1>and seeing that was a way of raising money to

0:35:46.080 --> 0:35:49.880
<v Speaker 1>to try to bring other canabinoid based medicines to to

0:35:50.040 --> 0:35:53.520
<v Speaker 1>market through the FDA approval process. But what Gw Farma

0:35:53.560 --> 0:35:58.040
<v Speaker 1>did was file many patent applications. I think they have

0:35:58.400 --> 0:36:02.400
<v Speaker 1>several hundred on purified forms of CBD and and all

0:36:02.440 --> 0:36:05.320
<v Speaker 1>the ways that CBD can be used in different types

0:36:05.360 --> 0:36:09.680
<v Speaker 1>of treatment. GW has patents covering CBD for just about

0:36:09.719 --> 0:36:12.880
<v Speaker 1>everything you can think. So in terms of this industry now,

0:36:12.880 --> 0:36:15.920
<v Speaker 1>I mean look, obviously when when the companies are engaged

0:36:15.960 --> 0:36:18.960
<v Speaker 1>in trying to come up with truly novel products, right,

0:36:19.120 --> 0:36:22.480
<v Speaker 1>new psychedelic substances in the way that Sasha was creating

0:36:22.520 --> 0:36:25.400
<v Speaker 1>in his backyard lab UM, or if they're trying to

0:36:25.440 --> 0:36:28.279
<v Speaker 1>create a new version of U, say AAHUASCA D Mt

0:36:28.719 --> 0:36:31.279
<v Speaker 1>Without the nausea or a shorter acting thing. I mean

0:36:31.280 --> 0:36:33.279
<v Speaker 1>there are some people who are out there just saying hey,

0:36:33.360 --> 0:36:36.399
<v Speaker 1>leave nature alone, we got what we need. We don't

0:36:36.440 --> 0:36:39.040
<v Speaker 1>need new synthetic creations but I think most people would

0:36:39.040 --> 0:36:42.279
<v Speaker 1>say no, you know, uh, individuals, the companies should be

0:36:42.360 --> 0:36:45.560
<v Speaker 1>free to try to create other novel psychelic substances that

0:36:45.880 --> 0:36:48.360
<v Speaker 1>may be enhanced the benefits of what nature has already

0:36:48.360 --> 0:36:51.399
<v Speaker 1>produced or reduced the downsides, or that can be more

0:36:51.400 --> 0:36:54.600
<v Speaker 1>efficacious in various ways or more naturally tailored to treat

0:36:54.640 --> 0:36:57.840
<v Speaker 1>certain conditions. Right. But what we also know is that,

0:36:57.880 --> 0:37:00.200
<v Speaker 1>whether we're talking about the psychedelics are almost any other here,

0:37:00.400 --> 0:37:02.960
<v Speaker 1>that the vast majority are not really about that. So

0:37:03.000 --> 0:37:05.080
<v Speaker 1>I was reading recently, I don't know when exactly this

0:37:05.160 --> 0:37:07.719
<v Speaker 1>piece was written, but it said that if you look

0:37:07.719 --> 0:37:11.360
<v Speaker 1>at the top five public psychedelics companies by market CAP,

0:37:11.520 --> 0:37:14.160
<v Speaker 1>so a Thaie life sciences, which invest in a range

0:37:14.160 --> 0:37:17.000
<v Speaker 1>of other companies, compass, which we've talked about, mind mead,

0:37:17.080 --> 0:37:20.400
<v Speaker 1>which you've mentioned, and also G H research in Cybin,

0:37:20.920 --> 0:37:23.439
<v Speaker 1>they've already submitted or owned the rights to at least

0:37:23.440 --> 0:37:28.160
<v Speaker 1>a hundred fifty seven patents, with undoubtedly hundreds more in

0:37:28.200 --> 0:37:32.719
<v Speaker 1>the pipeline. So what I'm curious there is that, I mean,

0:37:32.920 --> 0:37:35.480
<v Speaker 1>is this all sort of, you know, ultimately going to

0:37:35.560 --> 0:37:38.120
<v Speaker 1>turn out? I mean, whatever value added it happens here.

0:37:38.200 --> 0:37:40.600
<v Speaker 1>I assume that most of these are not novel products.

0:37:40.640 --> 0:37:43.279
<v Speaker 1>A lot of them are all forms of administration or

0:37:43.560 --> 0:37:46.160
<v Speaker 1>you know synthesis that are not all that crucial to

0:37:46.239 --> 0:37:49.680
<v Speaker 1>the advances. I assume that many of them their market

0:37:49.760 --> 0:37:52.799
<v Speaker 1>cap value is based upon how likely they are to

0:37:52.920 --> 0:37:56.200
<v Speaker 1>get a patent and that's primarily what's drawing, you know,

0:37:56.280 --> 0:37:59.000
<v Speaker 1>driving them. So I'm wondering, are we all headed in

0:37:59.040 --> 0:38:01.720
<v Speaker 1>the wrong direction on this thing, or is there any

0:38:01.920 --> 0:38:05.799
<v Speaker 1>collaborative effort among the leaders, the for profit leaders um

0:38:05.800 --> 0:38:09.880
<v Speaker 1>together was say, Rick Dolbin's maps or or carry Turnbull's

0:38:10.000 --> 0:38:13.120
<v Speaker 1>Um Freedom to operate? So two part question. Is it

0:38:13.200 --> 0:38:15.400
<v Speaker 1>all heading the wrong direction and is there any collaborative

0:38:15.400 --> 0:38:19.000
<v Speaker 1>effort to try to write this? Well, yeah, those are

0:38:19.000 --> 0:38:23.480
<v Speaker 1>really food questions. I mean I maybe I'll start with

0:38:23.520 --> 0:38:25.680
<v Speaker 1>the second because it's the easiest one, because it's just

0:38:25.800 --> 0:38:28.600
<v Speaker 1>the answer at least, is I don't know, and perhaps

0:38:28.640 --> 0:38:31.719
<v Speaker 1>I don't think so. I mean I certainly think that

0:38:31.719 --> 0:38:34.880
<v Speaker 1>there could be ways of collaborating, but just in terms

0:38:34.880 --> 0:38:38.160
<v Speaker 1>of the way the system is set up and that

0:38:38.280 --> 0:38:40.839
<v Speaker 1>this is not something about just perhaps psychedelics, but just

0:38:40.880 --> 0:38:44.520
<v Speaker 1>about the you know, the way are are just corporate

0:38:44.840 --> 0:38:48.480
<v Speaker 1>ecosystem and broader capitalist system is structured. You know, I don't.

0:38:48.480 --> 0:38:50.520
<v Speaker 1>I don't think these companies are necessarily going to pair

0:38:50.640 --> 0:38:54.600
<v Speaker 1>with AH nonprofits and and and try to work together.

0:38:54.760 --> 0:38:58.560
<v Speaker 1>I know that their investors would want that. Um, maybe

0:38:58.600 --> 0:39:01.319
<v Speaker 1>to answer one thing just that you didn't ask, which

0:39:01.360 --> 0:39:04.600
<v Speaker 1>was just about the number of patents. I mean you're

0:39:04.680 --> 0:39:07.600
<v Speaker 1>right to call the very large number of them, but

0:39:07.719 --> 0:39:10.920
<v Speaker 1>I think part of this is just because with any

0:39:11.080 --> 0:39:14.080
<v Speaker 1>even individual drug there are dozens, if not hundreds, of

0:39:14.080 --> 0:39:16.960
<v Speaker 1>patents filed on just like a single drug. So I

0:39:17.000 --> 0:39:21.880
<v Speaker 1>don't think all of these will reflect necessarily novel compounds

0:39:21.960 --> 0:39:25.200
<v Speaker 1>or novel ways of really doing things. In terms of

0:39:25.200 --> 0:39:29.200
<v Speaker 1>our we all pointed in the wrong direction. You know,

0:39:29.880 --> 0:39:34.120
<v Speaker 1>I often go back, um to something I heard at horizons,

0:39:34.280 --> 0:39:37.239
<v Speaker 1>which was Joe Green at the Business Day saying that

0:39:37.640 --> 0:39:40.760
<v Speaker 1>in Oregon it costs five and a half million dollars

0:39:40.800 --> 0:39:43.600
<v Speaker 1>to bring measure one o nine through, and I don't

0:39:43.600 --> 0:39:46.040
<v Speaker 1>know what it costs to get measure one tent through,

0:39:46.080 --> 0:39:48.480
<v Speaker 1>but I know I would imagine it's something on that

0:39:48.520 --> 0:39:51.200
<v Speaker 1>same order. Now, if we think of all these companies,

0:39:51.200 --> 0:39:53.040
<v Speaker 1>and by the way, for our listeners, one oh nine,

0:39:53.280 --> 0:39:57.680
<v Speaker 1>Um was was the initiative in Oregon to legalized psycholic therapy.

0:39:58.160 --> 0:40:00.080
<v Speaker 1>And the one ten is the one that was D

0:40:00.239 --> 0:40:03.360
<v Speaker 1>by Drug Policy Alliance under my successors, together with allies

0:40:03.360 --> 0:40:06.080
<v Speaker 1>in Oregon, which is essentially a Portugal model, the all

0:40:06.160 --> 0:40:10.520
<v Speaker 1>drug decrim and a siphoning money over to treatment for addiction.

0:40:10.880 --> 0:40:13.960
<v Speaker 1>So yeah, right now and that you're good to describe those.

0:40:13.960 --> 0:40:17.280
<v Speaker 1>So yeah, so obviously one to measure to get drug

0:40:18.040 --> 0:40:22.000
<v Speaker 1>or PSILOCYBIN therapy legalizing and one for decriminalization, and both

0:40:22.040 --> 0:40:24.279
<v Speaker 1>just in one state, in Oregon. But let's say even

0:40:24.280 --> 0:40:26.399
<v Speaker 1>together it was, you know, it's something on the order

0:40:26.440 --> 0:40:29.200
<v Speaker 1>of ten million dollars. And so calling this out to

0:40:29.280 --> 0:40:33.480
<v Speaker 1>say at Horizons Um that you know the amount of

0:40:33.480 --> 0:40:36.080
<v Speaker 1>money that's raised by all of these companies, so g

0:40:36.320 --> 0:40:40.839
<v Speaker 1>h Pharma, Atie, compass, mind met the others, many, many

0:40:40.960 --> 0:40:44.520
<v Speaker 1>orders of magnitude more than ten millions of ten million dollars.

0:40:44.560 --> 0:40:49.160
<v Speaker 1>So are we pointing the wrong direction? Maybe the question is,

0:40:49.160 --> 0:40:53.640
<v Speaker 1>is putting all this money in drug development, in patent filings?

0:40:53.960 --> 0:40:55.680
<v Speaker 1>Is that going the wrong direction? Mean what would all

0:40:55.680 --> 0:40:58.760
<v Speaker 1>this money do if it was put into drug policy

0:40:58.840 --> 0:41:02.759
<v Speaker 1>or form into a to decriminalize drugs at the state level?

0:41:02.840 --> 0:41:07.400
<v Speaker 1>And to attempts to provide other legally legalized, regulated Um

0:41:07.480 --> 0:41:11.479
<v Speaker 1>ways to access psychedelics, like what measure one on nine

0:41:11.719 --> 0:41:15.200
<v Speaker 1>is going to do an Oregon Um. And so, you know,

0:41:15.239 --> 0:41:18.440
<v Speaker 1>it's a question, I suppose, of just kind of priorities, um,

0:41:18.560 --> 0:41:22.719
<v Speaker 1>but but it is something that I think, uh, depending on,

0:41:23.280 --> 0:41:25.480
<v Speaker 1>you know, what what you see as being the sort

0:41:25.480 --> 0:41:29.920
<v Speaker 1>of ideal orientation for a future psychedelics market, that perhaps

0:41:30.040 --> 0:41:32.680
<v Speaker 1>we could be pointing away from it. Because what I

0:41:32.680 --> 0:41:34.400
<v Speaker 1>worry about old say is I look, you know, another

0:41:34.440 --> 0:41:36.399
<v Speaker 1>issue that I was involved in deeply was the one

0:41:36.400 --> 0:41:39.480
<v Speaker 1>around overdose and making the locks zone more available. And that,

0:41:39.760 --> 0:41:42.400
<v Speaker 1>you know, the lock zone was patented, uh, I don't know,

0:41:42.520 --> 0:41:45.360
<v Speaker 1>sixty years or so by Jack Fishman and a few others.

0:41:45.440 --> 0:41:48.000
<v Speaker 1>It was not a big profit thing that patent ran out.

0:41:48.200 --> 0:41:50.319
<v Speaker 1>But then you have one company that comes along and

0:41:50.320 --> 0:41:53.440
<v Speaker 1>produces a nasal spray version and another one that produces

0:41:53.480 --> 0:41:56.040
<v Speaker 1>an auto injective version. So they're making a little easier

0:41:56.040 --> 0:41:58.960
<v Speaker 1>for people to administer and then they do everything possible

0:41:59.080 --> 0:42:01.560
<v Speaker 1>to try to block others from coming into that. And

0:42:01.640 --> 0:42:05.600
<v Speaker 1>the face of a massive over those fatality crisis, you know,

0:42:05.640 --> 0:42:08.600
<v Speaker 1>we have these products of Deloson, which has cost pennies

0:42:08.719 --> 0:42:11.480
<v Speaker 1>or maybe dollars to make, but the products are being

0:42:11.520 --> 0:42:14.160
<v Speaker 1>sold for, you know, you know, tens of dollars, if

0:42:14.160 --> 0:42:17.680
<v Speaker 1>not hundreds of dollars. And so is that a risk

0:42:18.000 --> 0:42:21.440
<v Speaker 1>in this psychedelics area, in the psychedelic Strap Ay area,

0:42:21.600 --> 0:42:24.120
<v Speaker 1>are we going to see an issue where, in fact,

0:42:24.280 --> 0:42:27.000
<v Speaker 1>some of the first companies to succeed in getting patents

0:42:27.560 --> 0:42:32.319
<v Speaker 1>land up blocking significant innovations and reductions and cost in

0:42:32.360 --> 0:42:34.239
<v Speaker 1>the way that we saw happen, for example, in the

0:42:34.320 --> 0:42:36.799
<v Speaker 1>the loxone area? I mean, I definitely do see that

0:42:36.800 --> 0:42:39.319
<v Speaker 1>that's a concern and that really just is the way

0:42:39.360 --> 0:42:43.640
<v Speaker 1>the patent system plays itself out. The benefit of the

0:42:43.680 --> 0:42:46.080
<v Speaker 1>patent to the patent holder is that they can set

0:42:46.200 --> 0:42:49.400
<v Speaker 1>prices however they want. That's the monopoly power that the

0:42:49.440 --> 0:42:52.839
<v Speaker 1>patent gives them and I think in just about every

0:42:52.840 --> 0:42:55.400
<v Speaker 1>instance with pharmaceutical drugs, they tend to go up in

0:42:55.480 --> 0:42:59.960
<v Speaker 1>price as the patent life goes along because the company

0:43:00.200 --> 0:43:03.080
<v Speaker 1>has the ability to set those prices on their own.

0:43:03.160 --> 0:43:05.759
<v Speaker 1>And so I mean to myself, this is something I'm

0:43:05.840 --> 0:43:08.400
<v Speaker 1>very sensitive too because as a type one diabetic, I

0:43:08.480 --> 0:43:12.319
<v Speaker 1>use insulin and insulin I think like a Oxon very

0:43:12.360 --> 0:43:14.960
<v Speaker 1>famously was was patented many, many years ago, and actually

0:43:15.080 --> 0:43:17.400
<v Speaker 1>that the pattern was sold to a university for a

0:43:17.480 --> 0:43:21.960
<v Speaker 1>dollar because the inventor wanted insulin to be broadly available.

0:43:22.040 --> 0:43:25.480
<v Speaker 1>And people now, a hundred years later, still might pay

0:43:25.680 --> 0:43:28.000
<v Speaker 1>over a thousand dollars a month for it Um and

0:43:28.080 --> 0:43:32.320
<v Speaker 1>so similarly, I think in the pharmaceutical space companies know

0:43:32.480 --> 0:43:35.000
<v Speaker 1>how to play these games with their their patents, to

0:43:35.040 --> 0:43:38.920
<v Speaker 1>extend patent life and patent protection, to find ways to

0:43:39.960 --> 0:43:44.440
<v Speaker 1>patent tweaks to a molecule or delivery device or a

0:43:44.560 --> 0:43:49.640
<v Speaker 1>way that it's being offered, to continue to be able

0:43:49.680 --> 0:43:53.120
<v Speaker 1>to raise prices and exclude competition. So I do see

0:43:53.200 --> 0:43:59.359
<v Speaker 1>that once the psychedelics enter the pharmaceutical system is at large,

0:43:59.600 --> 0:44:03.040
<v Speaker 1>those suffer from all the same structural failures of the

0:44:03.440 --> 0:44:09.360
<v Speaker 1>broader patent system within the pharmaceutical industry. Let's take a

0:44:09.400 --> 0:44:25.239
<v Speaker 1>break here and go to an ad. So when it

0:44:25.320 --> 0:44:28.799
<v Speaker 1>comes to solutions, right, so there's the big picture one, right,

0:44:28.880 --> 0:44:32.040
<v Speaker 1>which is about the overall patent system being broken. Right.

0:44:32.200 --> 0:44:34.680
<v Speaker 1>So The New York Times earlier this year had a

0:44:34.880 --> 0:44:39.759
<v Speaker 1>huge editorial called Save America's patent system. You know about how,

0:44:39.920 --> 0:44:42.719
<v Speaker 1>fundamentally broken it is and what needs to be done.

0:44:43.080 --> 0:44:45.040
<v Speaker 1>And then there was a very good article, I think

0:44:45.120 --> 0:44:47.359
<v Speaker 1>you've quoted various places, by one of the smartest young

0:44:47.440 --> 0:44:50.719
<v Speaker 1>journalists covering the psychedelics field, Shalah love, and the title

0:44:50.800 --> 0:44:53.600
<v Speaker 1>of her piece was psychedelic patents are broken because the

0:44:53.680 --> 0:44:57.560
<v Speaker 1>patent system is broken. So we're talking about patent reform

0:44:57.719 --> 0:45:00.680
<v Speaker 1>in the US. Is Anything on the horizon thin or

0:45:00.719 --> 0:45:03.040
<v Speaker 1>are we just kind of doomed to keep living with

0:45:03.160 --> 0:45:05.640
<v Speaker 1>this for years the way it is? Well, I hope

0:45:05.680 --> 0:45:07.440
<v Speaker 1>you don't have to end here, because how do to

0:45:07.600 --> 0:45:11.360
<v Speaker 1>some degree think that we in a sense are doomed,

0:45:11.400 --> 0:45:14.560
<v Speaker 1>at least with the patent system we have, especially when

0:45:14.560 --> 0:45:18.680
<v Speaker 1>it comes to the pharmaceutical space, because the pharmaceutical lobby

0:45:18.840 --> 0:45:22.239
<v Speaker 1>is really one of the strongest and the pharmaceutical lobby

0:45:22.280 --> 0:45:24.800
<v Speaker 1>has been doing all it can to keep the patent

0:45:24.840 --> 0:45:27.719
<v Speaker 1>system working in its favor. And so I think there

0:45:27.880 --> 0:45:30.640
<v Speaker 1>certainly are efforts, and I will keep my fingers crossed

0:45:30.680 --> 0:45:34.000
<v Speaker 1>that these efforts can be successful, both in terms of

0:45:34.600 --> 0:45:37.400
<v Speaker 1>sort of at the individual level, like with what the

0:45:37.520 --> 0:45:40.920
<v Speaker 1>hey utilius are doing, making sure individual patents are are

0:45:41.040 --> 0:45:44.000
<v Speaker 1>are granted fairly, and in view of all the proper

0:45:44.360 --> 0:45:47.200
<v Speaker 1>prior art Um. I think, for broadly that the patent

0:45:47.239 --> 0:45:51.719
<v Speaker 1>system itself. There are things that are being worked out

0:45:51.760 --> 0:45:55.520
<v Speaker 1>through other reform bills that have been introduced in I

0:45:55.560 --> 0:45:57.480
<v Speaker 1>think there's still a chance there can be something that

0:45:57.560 --> 0:46:02.640
<v Speaker 1>might raise the standards so that pharmaceutical innovation actually occurs.

0:46:02.719 --> 0:46:06.680
<v Speaker 1>I mean, despite the fact that hundreds of pharmaceutical patents

0:46:06.719 --> 0:46:09.799
<v Speaker 1>are granted every year, it's a or on every drug,

0:46:09.960 --> 0:46:12.600
<v Speaker 1>even it's a very small number of them that actually

0:46:12.640 --> 0:46:16.360
<v Speaker 1>provide any real innovation in terms of patient outcomes and

0:46:16.440 --> 0:46:18.880
<v Speaker 1>in terms of clinical benefits. Um. But I mean I

0:46:18.960 --> 0:46:23.320
<v Speaker 1>think even Perdue Pharma right effectively extended the patent or

0:46:23.400 --> 0:46:25.680
<v Speaker 1>got a new one on its oxy content just by

0:46:25.680 --> 0:46:29.800
<v Speaker 1>a slight reformulation and effective interactions with FDA. And I

0:46:29.840 --> 0:46:31.800
<v Speaker 1>think what they were doing was fairly typical. Right, you

0:46:31.920 --> 0:46:34.560
<v Speaker 1>have a kind of medication which maybe a breakthrough or

0:46:34.640 --> 0:46:37.520
<v Speaker 1>semi breakthrough, but then just by tinkering it with it,

0:46:37.640 --> 0:46:40.880
<v Speaker 1>they just keep extending their protections, patent protections, keeping the

0:46:40.960 --> 0:46:45.000
<v Speaker 1>cost up, blocking generics and uh, and and yet you know,

0:46:45.160 --> 0:46:48.560
<v Speaker 1>for all the politicians saying we need to fix this Um,

0:46:49.000 --> 0:46:50.920
<v Speaker 1>not much is happening. I think that's right, and I

0:46:50.960 --> 0:46:53.440
<v Speaker 1>mean it's it's wrapped up inside, you know, broader reform

0:46:53.520 --> 0:46:57.080
<v Speaker 1>to to just the healthcare system and the way insurance

0:46:57.320 --> 0:47:01.920
<v Speaker 1>covers drugs and health care more broadly. And so it

0:47:02.120 --> 0:47:04.359
<v Speaker 1>is in terms of a structure to look out at

0:47:04.520 --> 0:47:09.120
<v Speaker 1>from within the the PSYCHEDELIC space. It's something that is

0:47:09.239 --> 0:47:13.880
<v Speaker 1>pretty daunting to think that the ethos of the psychedelic

0:47:13.920 --> 0:47:16.600
<v Speaker 1>space somehow can be used as a as a model

0:47:16.680 --> 0:47:20.360
<v Speaker 1>to reimagine the pharmaceutical patent system at large. But I

0:47:20.400 --> 0:47:23.520
<v Speaker 1>think there are ways to that. Companies within the PSYCHEDELIC

0:47:23.600 --> 0:47:26.239
<v Speaker 1>space can choose to interact with the patent system a

0:47:26.239 --> 0:47:29.239
<v Speaker 1>little bit differently and there have been some examples of

0:47:29.360 --> 0:47:31.640
<v Speaker 1>some companies who have made some attempts to do that

0:47:31.760 --> 0:47:36.040
<v Speaker 1>and I think it certainly is something that's on people's

0:47:36.200 --> 0:47:39.600
<v Speaker 1>minds in the PSYCHEDELIC space. And so I think just

0:47:39.760 --> 0:47:42.160
<v Speaker 1>the fact that so many people are talking about psychedelics

0:47:42.160 --> 0:47:44.719
<v Speaker 1>patterns and see them as a as a problem, means

0:47:44.800 --> 0:47:48.960
<v Speaker 1>that companies will, to the extent they have uh, you know,

0:47:49.480 --> 0:47:53.120
<v Speaker 1>consumers of their of their products, concerned with what they're doing,

0:47:53.280 --> 0:47:56.560
<v Speaker 1>perhaps can be held to higher standard. Well, you know,

0:47:56.680 --> 0:47:58.720
<v Speaker 1>I see. I mean if you look at the proactive efforts.

0:47:58.719 --> 0:48:02.640
<v Speaker 1>I mean we've discussed free to operate, right carry Turnbull's operation,

0:48:02.800 --> 0:48:05.399
<v Speaker 1>which try to block compass. But you know, there's also

0:48:05.480 --> 0:48:08.640
<v Speaker 1>this thing called Porta Sophia, right, which tries to address

0:48:08.680 --> 0:48:11.080
<v Speaker 1>the issue with prior art and to try to make

0:48:11.520 --> 0:48:13.719
<v Speaker 1>sort of create a database of all the prior art,

0:48:13.840 --> 0:48:16.719
<v Speaker 1>you know, the pre existing you know, types of uses

0:48:16.800 --> 0:48:19.400
<v Speaker 1>of these drugs so that people can't falsely make claims

0:48:19.400 --> 0:48:21.680
<v Speaker 1>for patents. And there's, I think you're, you're you're, a

0:48:21.719 --> 0:48:26.200
<v Speaker 1>thing called Psychedelic Alpha Dot COM um, which provides, you know,

0:48:26.320 --> 0:48:29.279
<v Speaker 1>a pretty good listing of all this. Just tell tell

0:48:29.360 --> 0:48:31.879
<v Speaker 1>us a little more about what's going on with your

0:48:32.000 --> 0:48:36.080
<v Speaker 1>thing and and port to Sophia, their significance and are

0:48:36.160 --> 0:48:38.560
<v Speaker 1>those sorts of ideas that come that are all settening

0:48:38.600 --> 0:48:41.920
<v Speaker 1>in other areas of non, you know, psychoactive drug areas?

0:48:42.160 --> 0:48:44.720
<v Speaker 1>Maybe to the place to start with the Psychedelic Alpha

0:48:45.920 --> 0:48:48.160
<v Speaker 1>is actually to sort of go back to the origin

0:48:48.280 --> 0:48:52.640
<v Speaker 1>stories of it. Um, I actually was volunteering at a

0:48:52.719 --> 0:48:55.240
<v Speaker 1>at a maps INFO table at a at a conference

0:48:55.280 --> 0:48:58.319
<v Speaker 1>that just coincidentally happened to be the weekend after an

0:48:58.400 --> 0:49:02.560
<v Speaker 1>article by Olivia Gold Hill published on compasses first patent.

0:49:02.960 --> 0:49:06.600
<v Speaker 1>It hadn't yet published but they had Um told people

0:49:06.640 --> 0:49:09.440
<v Speaker 1>about its filing and that it was on Psilocybin, and

0:49:10.160 --> 0:49:13.640
<v Speaker 1>this article was really the first to kind of raise

0:49:13.719 --> 0:49:17.640
<v Speaker 1>the outrage and because I mentioned everyone there that I

0:49:17.719 --> 0:49:20.279
<v Speaker 1>was a patent lawyer, I spent basically the weekend talking

0:49:20.320 --> 0:49:23.239
<v Speaker 1>about uh Psilocybin patents and how it could be even

0:49:23.320 --> 0:49:26.719
<v Speaker 1>possible to file a patent on PSILOCYBIN. And after I

0:49:27.200 --> 0:49:30.040
<v Speaker 1>left the conference that weekend and went home, I started

0:49:30.120 --> 0:49:34.840
<v Speaker 1>keeping track of a table of patents on Psilocybin in particular,

0:49:35.160 --> 0:49:37.680
<v Speaker 1>at which point there were maybe a dozen and probably

0:49:37.719 --> 0:49:40.400
<v Speaker 1>not very many more, including the ones at Albert Hoffman

0:49:40.400 --> 0:49:43.080
<v Speaker 1>had filed that Sandos. Since then, of course, now there

0:49:43.160 --> 0:49:47.200
<v Speaker 1>are are many hundreds and because patent applications aren't published

0:49:47.280 --> 0:49:50.200
<v Speaker 1>until eighteen months after they're filed, there there's probably even

0:49:50.800 --> 0:49:53.880
<v Speaker 1>twice or three times as many now, but most of

0:49:53.960 --> 0:49:58.359
<v Speaker 1>them still just secret. That is not only something that's

0:49:58.400 --> 0:50:00.320
<v Speaker 1>in the in the PSYCHEDELIC space. I mean part of

0:50:00.320 --> 0:50:03.440
<v Speaker 1>the reason I decided it would be worthwhile publishing it

0:50:03.520 --> 0:50:07.120
<v Speaker 1>on Psychedelic Alpha was because it was, you know, a

0:50:07.200 --> 0:50:09.719
<v Speaker 1>good way of making people aware of the types of

0:50:09.760 --> 0:50:12.440
<v Speaker 1>applications that were out there and and sort of starting

0:50:12.480 --> 0:50:16.960
<v Speaker 1>a conversation around them. But there's an organization called IMAC,

0:50:17.320 --> 0:50:21.040
<v Speaker 1>the initiative for medicines access and knowledge, which I use

0:50:21.080 --> 0:50:25.040
<v Speaker 1>their statistics a lot. I Am A K right, a

0:50:25.200 --> 0:50:27.560
<v Speaker 1>k dit org, which I think was an important source

0:50:27.640 --> 0:50:30.640
<v Speaker 1>for that New York Times editorial and it's been taking

0:50:30.680 --> 0:50:32.960
<v Speaker 1>on some of these issues in a broader way. So yeah,

0:50:33.080 --> 0:50:36.080
<v Speaker 1>very much so, yes, and they've been sort of counting

0:50:36.160 --> 0:50:38.719
<v Speaker 1>and cataloging that the number of applications that have been

0:50:38.760 --> 0:50:44.440
<v Speaker 1>filed on of other pharmaceuticals, just in terms of seeing

0:50:44.840 --> 0:50:47.880
<v Speaker 1>the impact that they have on particular pharmaceutical drugs. And

0:50:48.000 --> 0:50:50.880
<v Speaker 1>so to some degree that was, I'd say, somewhat of

0:50:50.920 --> 0:50:55.200
<v Speaker 1>an inspiration, just seeing that a conversation can be started

0:50:55.280 --> 0:50:59.960
<v Speaker 1>around individual compounds through looking at the types of applications

0:51:00.000 --> 0:51:01.560
<v Speaker 1>that are filed on them and what that might mean

0:51:01.760 --> 0:51:05.080
<v Speaker 1>for the price of somebody using that that compound as

0:51:05.160 --> 0:51:09.879
<v Speaker 1>part of a medicine. Um. I see, and I think

0:51:09.920 --> 0:51:13.120
<v Speaker 1>even with Imac died or I MAAC, are they engaging

0:51:13.160 --> 0:51:15.600
<v Speaker 1>in some ways in the psychological area or they are

0:51:15.680 --> 0:51:18.319
<v Speaker 1>familiar with it? Are you in contact with them? Well, yeah,

0:51:18.480 --> 0:51:23.640
<v Speaker 1>so they're co founder, Prett Crystal has um actually been

0:51:23.719 --> 0:51:27.759
<v Speaker 1>on a panel with me with Shakruna, Um, speaking of

0:51:27.960 --> 0:51:32.680
<v Speaker 1>Sheila love. I think Um really is, uh, the best

0:51:32.760 --> 0:51:37.160
<v Speaker 1>writer on on pharmaceutical or on psychedelic patents in this

0:51:37.239 --> 0:51:40.440
<v Speaker 1>space and and certainly everyone should read but she's written

0:51:40.440 --> 0:51:45.760
<v Speaker 1>about this. Um, she and Um Actually Josh Hardman and myself,

0:51:45.840 --> 0:51:49.560
<v Speaker 1>and pretty crystal proposed a panel itself. By southwest is

0:51:49.600 --> 0:51:51.680
<v Speaker 1>coming here, so we hope we can all speak together.

0:51:51.800 --> 0:51:54.479
<v Speaker 1>So we have, of course also been speaking a little

0:51:54.480 --> 0:51:58.080
<v Speaker 1>bit together in general and see that we're aligned in

0:51:58.239 --> 0:52:00.880
<v Speaker 1>terms of what we hope to see. For you know,

0:52:00.960 --> 0:52:03.719
<v Speaker 1>the psychedelic spaces is very similar to the types of

0:52:03.760 --> 0:52:07.040
<v Speaker 1>reforms that Imac for for decades now, has argued are

0:52:07.200 --> 0:52:11.760
<v Speaker 1>necessary in the broader medicine space. And and and preachy

0:52:11.880 --> 0:52:16.040
<v Speaker 1>had done really great work arguing around access to AIDS,

0:52:16.160 --> 0:52:19.680
<v Speaker 1>medications and and other drugs for for many years, even

0:52:19.719 --> 0:52:22.319
<v Speaker 1>before she started Imac, and has has long been an

0:52:22.400 --> 0:52:27.600
<v Speaker 1>advocate for more equitable access to pharmaceuticals, and so definitely

0:52:27.680 --> 0:52:30.719
<v Speaker 1>saw both that as a resource but also as an

0:52:30.840 --> 0:52:35.560
<v Speaker 1>inspiration for sort of the ways that would be useful

0:52:35.640 --> 0:52:38.360
<v Speaker 1>to sort of Orient Um ethics in the in the

0:52:38.400 --> 0:52:42.840
<v Speaker 1>psychedolic space itself. So Graham normally asked this the beginning.

0:52:42.960 --> 0:52:46.359
<v Speaker 1>But how did you get intold, I mean I've I've

0:52:46.400 --> 0:52:48.959
<v Speaker 1>heard you talk about growing up in the west coast

0:52:49.040 --> 0:52:52.040
<v Speaker 1>with Hippie parents and getting involved at a young age

0:52:52.120 --> 0:52:54.440
<v Speaker 1>on UH. You know, I think you said you've been

0:52:54.440 --> 0:52:56.000
<v Speaker 1>involved with the prop two fifteen in the Middle Ca

0:52:56.040 --> 0:52:58.800
<v Speaker 1>Marojuina initiative twenty five years ago. But just teleraudience a

0:52:58.800 --> 0:53:01.960
<v Speaker 1>little more about your evel Lucian uh into becoming one

0:53:02.040 --> 0:53:05.480
<v Speaker 1>of the leading patent lawyers working in this area. Yeah, yeah,

0:53:05.480 --> 0:53:08.560
<v Speaker 1>I think maybe going back to that Um property fifteen

0:53:08.640 --> 0:53:10.680
<v Speaker 1>is but sort of how I draw my origin story,

0:53:10.719 --> 0:53:14.279
<v Speaker 1>although I suppose maybe the fortune of growing up in

0:53:14.520 --> 0:53:16.520
<v Speaker 1>Oakland too. I mean so I do mention, you know,

0:53:16.600 --> 0:53:18.600
<v Speaker 1>my my mom went to Berkeley in the Sixties and

0:53:19.400 --> 0:53:21.600
<v Speaker 1>Um my dad did have his share of long hair,

0:53:21.600 --> 0:53:23.560
<v Speaker 1>although I don't think they were either, the two of them,

0:53:23.920 --> 0:53:26.759
<v Speaker 1>that much into psychedelics. And so I grew up with

0:53:27.400 --> 0:53:29.239
<v Speaker 1>be here now sort of as a coffee table book

0:53:29.280 --> 0:53:31.680
<v Speaker 1>and you know, Carlos Castaneda and other books on the

0:53:31.960 --> 0:53:34.239
<v Speaker 1>the bookshelves. That sort of piqued my interest. And so

0:53:34.360 --> 0:53:36.239
<v Speaker 1>I was kind of a stoner in high school and

0:53:36.400 --> 0:53:38.600
<v Speaker 1>when proper to fifteen was on the ballot. Actually one

0:53:38.600 --> 0:53:40.920
<v Speaker 1>of the first things I did was, when I had

0:53:40.960 --> 0:53:44.560
<v Speaker 1>my driver's license, go collect signatures for the ballot on

0:53:45.400 --> 0:53:47.200
<v Speaker 1>in front, in front of a couple of grocery stores.

0:53:47.400 --> 0:53:53.000
<v Speaker 1>And in college, fairly early I had my first psychedelic

0:53:53.080 --> 0:53:58.400
<v Speaker 1>experiences and I had so much inspiration from those that

0:53:58.520 --> 0:54:02.080
<v Speaker 1>I changed my major to, you neuroscience, to try to

0:54:02.480 --> 0:54:06.680
<v Speaker 1>both learn a little bit more about how it had

0:54:06.719 --> 0:54:10.520
<v Speaker 1>those impacts on my on my consciousness, how chemicals like

0:54:10.600 --> 0:54:15.120
<v Speaker 1>that could have such a profound role in, uh, shifting

0:54:15.200 --> 0:54:17.160
<v Speaker 1>the way that I saw myself and saw the world.

0:54:17.560 --> 0:54:19.680
<v Speaker 1>Um and actually, for a time in college thought that

0:54:19.719 --> 0:54:24.440
<v Speaker 1>perhaps I could study a some sort of psychopharmacology or

0:54:25.000 --> 0:54:27.919
<v Speaker 1>I speaking of peakle and Tacl and I bought bought

0:54:27.960 --> 0:54:33.280
<v Speaker 1>those books Um and sort of saw Sasha. I suppose

0:54:33.360 --> 0:54:36.759
<v Speaker 1>it's something of a Um inspiration. And you know, I

0:54:36.880 --> 0:54:39.680
<v Speaker 1>received some encouragement from others that law school might be

0:54:39.719 --> 0:54:42.160
<v Speaker 1>a good way if I was interested in drug policy,

0:54:42.400 --> 0:54:46.400
<v Speaker 1>and so somewhat naively, I suppose, in retrospect, because thinking

0:54:46.440 --> 0:54:50.160
<v Speaker 1>I could work in cognitive liberty or something like drug

0:54:50.280 --> 0:54:54.279
<v Speaker 1>policy with law school loans. Um, it did end up

0:54:54.280 --> 0:54:57.920
<v Speaker 1>in law school but realized that the Science degree to

0:54:58.200 --> 0:55:01.279
<v Speaker 1>to pay off my loans was best used in the

0:55:02.000 --> 0:55:05.359
<v Speaker 1>the patent space, which was, you know, hiring it good

0:55:05.400 --> 0:55:08.239
<v Speaker 1>salaries and paying bonuses. And even though I had written

0:55:08.320 --> 0:55:11.719
<v Speaker 1>my law school term paper actually on the way that

0:55:12.239 --> 0:55:17.359
<v Speaker 1>generics are kept off the market by aggressive patent policies and, Um,

0:55:17.680 --> 0:55:22.120
<v Speaker 1>how drugs are are kept expensive by the sort of

0:55:22.200 --> 0:55:25.879
<v Speaker 1>abuse of the patent laws, it spent the first sort

0:55:25.880 --> 0:55:28.879
<v Speaker 1>of half decade of my career at a law firm

0:55:29.120 --> 0:55:32.720
<v Speaker 1>in New York working with branded drug companies to actually

0:55:32.840 --> 0:55:37.120
<v Speaker 1>keep generic drugs off the market for longer, Um, and

0:55:37.280 --> 0:55:40.120
<v Speaker 1>so to some degree I think I'm paying off that

0:55:40.239 --> 0:55:42.360
<v Speaker 1>Karma a little bit now. Well, I'm curious how you

0:55:42.480 --> 0:55:45.399
<v Speaker 1>balance that now, right and because obviously you know many

0:55:45.480 --> 0:55:48.440
<v Speaker 1>of your clients are going to be for profit companies

0:55:48.800 --> 0:55:51.120
<v Speaker 1>and are when you're talking with them or they want

0:55:51.160 --> 0:55:53.000
<v Speaker 1>to hire you, retain you or if you're already working

0:55:53.040 --> 0:55:55.200
<v Speaker 1>for them, are are there lines where you say look,

0:55:55.320 --> 0:55:58.640
<v Speaker 1>this is something I cannot make that argument here, or

0:55:58.680 --> 0:56:00.840
<v Speaker 1>do you turn down client who wants you to do

0:56:01.080 --> 0:56:03.520
<v Speaker 1>things that you don't feel or ethically right. I mean

0:56:03.520 --> 0:56:05.920
<v Speaker 1>because you're obviously out there as a forceful voice in

0:56:06.080 --> 0:56:08.759
<v Speaker 1>terms of it trying to advocate for good policies in

0:56:08.800 --> 0:56:11.400
<v Speaker 1>this area. You serve, you as an advisor to Chakruna,

0:56:11.480 --> 0:56:13.480
<v Speaker 1>you know, be able about these organizations doing a lot

0:56:13.520 --> 0:56:16.320
<v Speaker 1>of good work, but you're also, you know, a for profit.

0:56:16.360 --> 0:56:18.440
<v Speaker 1>I mean you were an attorney with clients. So how

0:56:18.480 --> 0:56:21.799
<v Speaker 1>do you balance that in your in your professional life? Yeah,

0:56:22.360 --> 0:56:24.120
<v Speaker 1>that I think is really the best, the best kind

0:56:24.120 --> 0:56:25.719
<v Speaker 1>of like the best question, and I think that is

0:56:26.440 --> 0:56:30.480
<v Speaker 1>the attention that I find myself trying to navigate and

0:56:31.040 --> 0:56:33.040
<v Speaker 1>spend a lot of my own time really thinking about.

0:56:33.680 --> 0:56:36.359
<v Speaker 1>I'm fortunately, I think that when I started my own firm,

0:56:36.440 --> 0:56:38.000
<v Speaker 1>to sort of go back a little bit before maybe

0:56:38.000 --> 0:56:43.320
<v Speaker 1>answering the question, when I started Calix Law in actually

0:56:43.360 --> 0:56:46.160
<v Speaker 1>that tension was sort of part of the reason for

0:56:46.280 --> 0:56:48.879
<v Speaker 1>even starting it. I had worked for a long time

0:56:48.960 --> 0:56:53.280
<v Speaker 1>on a case against Monsanto with their genetically modified crops

0:56:54.000 --> 0:57:00.360
<v Speaker 1>Um and I had obviously been very interested in cannabis

0:57:00.440 --> 0:57:02.200
<v Speaker 1>and that was part of the reason for wanting to

0:57:02.719 --> 0:57:06.280
<v Speaker 1>enter the cannabis space as a patent lawyer and because

0:57:06.320 --> 0:57:08.320
<v Speaker 1>of my interest in it. I had a number of

0:57:09.239 --> 0:57:11.920
<v Speaker 1>friends who are trying to go from the legacy market

0:57:11.960 --> 0:57:14.560
<v Speaker 1>into the sort of adult use market at the turn

0:57:14.640 --> 0:57:18.919
<v Speaker 1>of and sort of my thesis for starting my firm

0:57:19.080 --> 0:57:22.760
<v Speaker 1>was that there were ways for smaller inventors to get

0:57:22.840 --> 0:57:27.520
<v Speaker 1>involved with the patent system and two also used the

0:57:27.560 --> 0:57:30.520
<v Speaker 1>patent system to keep off a company like a Monsanto

0:57:30.880 --> 0:57:34.840
<v Speaker 1>or a Philip Morris from entering the cannabis space and

0:57:35.000 --> 0:57:37.160
<v Speaker 1>sort of taking it over and dominating it. And so

0:57:37.680 --> 0:57:41.760
<v Speaker 1>that sort of tension between seeing patents as ways of

0:57:42.960 --> 0:57:47.439
<v Speaker 1>giving a leg up to smaller, independent inventors, but also

0:57:47.560 --> 0:57:51.440
<v Speaker 1>as a way of keeping a market from being dominated

0:57:51.520 --> 0:57:58.120
<v Speaker 1>by aggressive monopolists. Um is sort of the kind of

0:57:58.400 --> 0:58:00.640
<v Speaker 1>premise that I even started my firm with, and so

0:58:01.680 --> 0:58:05.880
<v Speaker 1>taking that kind of thinking through to the psychedelic space,

0:58:06.760 --> 0:58:10.120
<v Speaker 1>I think that was part of the kind of fortune

0:58:10.200 --> 0:58:13.840
<v Speaker 1>that let me see that there were these issues around

0:58:14.600 --> 0:58:18.280
<v Speaker 1>pcybian patenting, for instance, Um, perhaps a bit earlier than

0:58:18.480 --> 0:58:20.600
<v Speaker 1>you know, maybe some others did, and so I think

0:58:20.640 --> 0:58:25.640
<v Speaker 1>I'm I'm fortunate for having spent some time talking about

0:58:25.720 --> 0:58:32.720
<v Speaker 1>those controversies that I actually do get presented with opportunities

0:58:32.760 --> 0:58:35.920
<v Speaker 1>to to try to find ways to to navigate them. Um,

0:58:37.000 --> 0:58:41.080
<v Speaker 1>from clients who who see patents as being necessary to

0:58:41.160 --> 0:58:44.680
<v Speaker 1>raise money. I have some clients who tried to go

0:58:44.800 --> 0:58:49.600
<v Speaker 1>without patents and just pursue their their work, uh, sort

0:58:49.640 --> 0:58:52.120
<v Speaker 1>of in the open, put things in the public domain,

0:58:52.280 --> 0:58:55.760
<v Speaker 1>and and sometimes found that they either couldn't raise money or,

0:58:56.000 --> 0:58:59.320
<v Speaker 1>in one instance, another company took an article that they

0:58:59.360 --> 0:59:02.520
<v Speaker 1>had published and filed patterns covering exactly what it was

0:59:02.560 --> 0:59:07.280
<v Speaker 1>that they had described. Um, and so I saw a

0:59:07.320 --> 0:59:09.280
<v Speaker 1>concern that like, well, if we don't file a pattern

0:59:09.320 --> 0:59:11.800
<v Speaker 1>for like, what if somebody else does? And so, Um,

0:59:12.840 --> 0:59:16.800
<v Speaker 1>I don't know that I've perhaps had to turn down

0:59:17.240 --> 0:59:20.560
<v Speaker 1>clients for wanting to unethically use the patent system, and

0:59:20.560 --> 0:59:23.040
<v Speaker 1>maybe I've just had the fortune of because I've been

0:59:23.200 --> 0:59:25.200
<v Speaker 1>to some degree of kind of a voice for for

0:59:25.360 --> 0:59:28.880
<v Speaker 1>balance in the patent system. Okay, so last questions here.

0:59:28.960 --> 0:59:31.400
<v Speaker 1>One of the issues that's been out there more and more,

0:59:32.000 --> 0:59:34.480
<v Speaker 1>and I know that Cody Swiss River Stix Foundation is

0:59:34.520 --> 0:59:37.520
<v Speaker 1>making this issue and others have, is what is owed

0:59:37.720 --> 0:59:42.680
<v Speaker 1>to indigenous peoples when the psychedelic products that, you know,

0:59:42.760 --> 0:59:48.440
<v Speaker 1>emerged from their indigenous uses start becoming commercialized, and so

0:59:48.760 --> 0:59:52.040
<v Speaker 1>you know I mean when we look at Mescaline and Peyote,

0:59:52.320 --> 0:59:54.920
<v Speaker 1>when we look at Eboga coming from cabone and the

0:59:55.000 --> 0:59:58.160
<v Speaker 1>surrounding areas in West Africa, I mean he's came so

0:59:58.400 --> 1:00:02.400
<v Speaker 1>much out of indigenous use, is mescal in Um. And

1:00:02.560 --> 1:00:05.760
<v Speaker 1>so it's a question what is owed and exactly to whom.

1:00:06.600 --> 1:00:09.920
<v Speaker 1>And then there's the broadening of the issues. So, for example,

1:00:09.960 --> 1:00:13.160
<v Speaker 1>when it comes to Psilocybin, mushrooms are growing, you know,

1:00:13.280 --> 1:00:15.520
<v Speaker 1>they grow all around the world and on the one

1:00:15.600 --> 1:00:19.400
<v Speaker 1>hand you hear the claim. Well, but for Maria Sabina

1:00:19.680 --> 1:00:23.680
<v Speaker 1>Educating Gordon Wasson, you know, sixty, seventy years ago. You know,

1:00:23.800 --> 1:00:26.600
<v Speaker 1>we want to have all these people aware of Psilocybin uh,

1:00:26.800 --> 1:00:28.200
<v Speaker 1>you know, in other parts of the world. But then

1:00:28.240 --> 1:00:30.120
<v Speaker 1>I think it's Paul stamens will say, well, hold on

1:00:30.120 --> 1:00:32.600
<v Speaker 1>a second. PSILOCYBIN has been actually used around the world

1:00:32.640 --> 1:00:34.880
<v Speaker 1>of different ways for a long time. So let's not

1:00:35.040 --> 1:00:39.080
<v Speaker 1>extend this indigenous obligation issue to PSILOCYBIN. And then, of course,

1:00:39.120 --> 1:00:41.160
<v Speaker 1>as m D M A, which is a twentieth century

1:00:41.600 --> 1:00:46.120
<v Speaker 1>synthetic creation Um, is anything owed from something like m

1:00:46.200 --> 1:00:49.560
<v Speaker 1>d m a UH to indigenous people? So what's your

1:00:49.680 --> 1:00:53.880
<v Speaker 1>view on on what is the proper obligations and and and,

1:00:54.360 --> 1:00:59.120
<v Speaker 1>to the extent there are obligations, how those should be addressed? Yeah, yeah,

1:00:59.120 --> 1:01:01.680
<v Speaker 1>I mean well, M D M A, even though Um,

1:01:01.840 --> 1:01:06.360
<v Speaker 1>I think, comes from Sasha's tinkering, so to speak, with mescaline.

1:01:06.480 --> 1:01:09.600
<v Speaker 1>So perhaps even there you could draw some degree through

1:01:09.680 --> 1:01:13.440
<v Speaker 1>line back to try to find some way to provide reciprocity.

1:01:13.480 --> 1:01:16.040
<v Speaker 1>I mean, if we speak in terms of legal obligations,

1:01:17.360 --> 1:01:20.680
<v Speaker 1>legally there really are none in the sense that there

1:01:20.800 --> 1:01:26.720
<v Speaker 1>are some treaties, there is something called the Nagoya Protocol,

1:01:26.840 --> 1:01:29.520
<v Speaker 1>but it hasn't been adopted by the US ratified by

1:01:29.520 --> 1:01:34.920
<v Speaker 1>the US, and so there's basically just the patent law,

1:01:34.960 --> 1:01:40.280
<v Speaker 1>which prevents companies from patenting something that are that's done

1:01:40.320 --> 1:01:44.240
<v Speaker 1>by somebody else. But there's certainly no mechanism for reciprocity.

1:01:44.320 --> 1:01:47.280
<v Speaker 1>It's in the law, unfortunately. So it really is up

1:01:47.360 --> 1:01:50.640
<v Speaker 1>to to us, I suppose, to decide what companies are

1:01:50.720 --> 1:01:53.960
<v Speaker 1>owed and to hold companies to account for that. In

1:01:54.120 --> 1:01:57.440
<v Speaker 1>terms of my own views, I mean I think this

1:01:57.560 --> 1:02:00.680
<v Speaker 1>all really comes down to just the broader controversy to

1:02:01.000 --> 1:02:06.160
<v Speaker 1>around patents, which is where the values derived from and

1:02:06.640 --> 1:02:11.040
<v Speaker 1>how much of that value gets extracted towards the the

1:02:11.120 --> 1:02:12.920
<v Speaker 1>owner of a patent or the the owner of a

1:02:13.400 --> 1:02:17.440
<v Speaker 1>group of patents. And we can look at not just

1:02:17.920 --> 1:02:21.880
<v Speaker 1>psilocybin but sort of any invention and I think any

1:02:21.920 --> 1:02:26.760
<v Speaker 1>invention to some degree, I think even the UH that

1:02:26.920 --> 1:02:28.800
<v Speaker 1>the saying goes. You know, we stand on the shoulders

1:02:28.840 --> 1:02:32.840
<v Speaker 1>of giants like nothing comes sue generous and even though

1:02:32.880 --> 1:02:36.440
<v Speaker 1>our patent system is served based on this ideal of

1:02:36.520 --> 1:02:41.000
<v Speaker 1>this kind of loan inventor genius working alone is workbench,

1:02:41.040 --> 1:02:43.400
<v Speaker 1>who sort has this Eureka moment where he comes up

1:02:43.440 --> 1:02:46.080
<v Speaker 1>with something that's never been done before and gets a

1:02:46.160 --> 1:02:48.280
<v Speaker 1>patent on it and is entitled to all the monopoly

1:02:48.360 --> 1:02:51.680
<v Speaker 1>profits on that for the next two decades. Nothing is

1:02:51.760 --> 1:02:57.280
<v Speaker 1>quite like that. And so how do we really find

1:02:57.320 --> 1:03:02.160
<v Speaker 1>a way to give some calculation to, you know, what

1:03:02.480 --> 1:03:06.920
<v Speaker 1>is Ode and you know, where does the value derive from, Um,

1:03:08.160 --> 1:03:13.440
<v Speaker 1>in terms of reciprocity, for for psychedelics? I mean, I

1:03:13.800 --> 1:03:18.520
<v Speaker 1>I certainly think that it's important to recognize that. You know,

1:03:18.600 --> 1:03:22.320
<v Speaker 1>many psychedelics come from these lineages where, whether they're just

1:03:22.800 --> 1:03:26.360
<v Speaker 1>from underground use like m D M A, dating back

1:03:26.440 --> 1:03:30.560
<v Speaker 1>to the seventies and eighties, whether they're from further back

1:03:30.720 --> 1:03:35.040
<v Speaker 1>than that, dating back to Maria Sabina or earlier, whether

1:03:35.080 --> 1:03:39.840
<v Speaker 1>they're getting back to, you know, potentially millennial use. Um.

1:03:40.480 --> 1:03:45.200
<v Speaker 1>I think having the conversation that that people are having, Um,

1:03:45.360 --> 1:03:47.800
<v Speaker 1>you know the question you're asking me, Um, not to

1:03:47.920 --> 1:03:50.960
<v Speaker 1>necessarily dodge it, but I think that's what's important and

1:03:51.040 --> 1:03:53.400
<v Speaker 1>I think it's you know it's even though I know

1:03:53.480 --> 1:03:55.400
<v Speaker 1>you asked my personal views. I mean, I think it's

1:03:56.320 --> 1:04:01.080
<v Speaker 1>an important decision for Vole to be making as the

1:04:01.280 --> 1:04:06.760
<v Speaker 1>PSYCHEDELIC space starts to mature more in terms of trying

1:04:06.800 --> 1:04:11.280
<v Speaker 1>to understand what the companies who make all the profits, uh,

1:04:11.640 --> 1:04:16.520
<v Speaker 1>should be responsible for. And I'm here again optimistic because

1:04:16.800 --> 1:04:20.800
<v Speaker 1>I see that there are many. Already you have found

1:04:20.840 --> 1:04:25.680
<v Speaker 1>ways to try to give some degree of reciprocity. Um.

1:04:26.200 --> 1:04:29.800
<v Speaker 1>There are companies who have given some portion of their

1:04:30.560 --> 1:04:34.080
<v Speaker 1>profits or said that they've dedicated some portion of their profits,

1:04:34.160 --> 1:04:39.520
<v Speaker 1>have given some of their equity, have provided other means

1:04:39.600 --> 1:04:43.320
<v Speaker 1>of reciprocity. At the same time, I've also spoken to

1:04:44.480 --> 1:04:50.800
<v Speaker 1>some indigenous people who feel like reciprocity, even as a term,

1:04:51.000 --> 1:04:55.000
<v Speaker 1>is perhaps not used correctly, in the sense that it's

1:04:55.000 --> 1:04:58.680
<v Speaker 1>only reciprocity if somebody accepts what you're giving to them.

1:04:58.760 --> 1:05:00.640
<v Speaker 1>And so just for a company to to say, well,

1:05:00.680 --> 1:05:04.280
<v Speaker 1>I'M gonna give ten percent back to the indigenous like that,

1:05:04.440 --> 1:05:07.520
<v Speaker 1>not only is perhaps not enough, but it's maybe even

1:05:08.680 --> 1:05:11.760
<v Speaker 1>a form of I know some people have called it

1:05:11.840 --> 1:05:15.040
<v Speaker 1>tied eye washing or greenwashing, but sort of, I guess,

1:05:15.800 --> 1:05:20.200
<v Speaker 1>avoiding a greater responsibility, which is perhaps what like the

1:05:20.720 --> 1:05:26.520
<v Speaker 1>Nagoya Protocol I mentioned requires, which is actually consulting with

1:05:27.000 --> 1:05:31.560
<v Speaker 1>the groups from which you're taking the knowledge or the

1:05:31.600 --> 1:05:35.960
<v Speaker 1>wisdom and before doing something that would give you the

1:05:36.000 --> 1:05:40.040
<v Speaker 1>profits that you would just give back, actually consulting, getting

1:05:40.080 --> 1:05:42.920
<v Speaker 1>informed consent and having a process at the beginning to

1:05:43.080 --> 1:05:47.000
<v Speaker 1>really share those those benefits. So last question, Graham. Do

1:05:47.160 --> 1:05:49.560
<v Speaker 1>you have a favorite psychedelic? And the part to that

1:05:49.720 --> 1:05:54.200
<v Speaker 1>question is can you think of any moments where you're

1:05:54.240 --> 1:06:00.240
<v Speaker 1>a psychedelic experience actually proved specifically helpful in addressing um

1:06:00.440 --> 1:06:04.040
<v Speaker 1>professional issues or questions that you were thinking through? Um? Well,

1:06:04.280 --> 1:06:10.400
<v Speaker 1>so my favorite PSYCHEDELIC is mushrooms. Um just just because

1:06:11.040 --> 1:06:15.720
<v Speaker 1>I love the I guess the fact that they're just

1:06:15.880 --> 1:06:20.360
<v Speaker 1>so tangible and they're very accessible and that you can

1:06:20.720 --> 1:06:23.880
<v Speaker 1>grow them quite easily yourself. You can find them places,

1:06:23.920 --> 1:06:27.400
<v Speaker 1>often when you're not even expecting to. Um. I love

1:06:27.480 --> 1:06:30.600
<v Speaker 1>just mushrooms in general and my my Fians, I and

1:06:30.720 --> 1:06:32.600
<v Speaker 1>I are I think our our favorite thing to do

1:06:32.680 --> 1:06:36.440
<v Speaker 1>together is a mushroom foraging Um, not usually for for

1:06:36.520 --> 1:06:40.240
<v Speaker 1>psychedelic mushrooms, but just generally Um. And so, you know,

1:06:40.280 --> 1:06:42.080
<v Speaker 1>I love the fact that they're just, you know, a

1:06:42.200 --> 1:06:47.040
<v Speaker 1>natural thing and they're they're also very well they're a

1:06:47.040 --> 1:06:49.480
<v Speaker 1>little bit variable, but they're much easier to dose than

1:06:49.560 --> 1:06:51.720
<v Speaker 1>than other things, since you can see exactly what it

1:06:51.800 --> 1:06:56.920
<v Speaker 1>is you're you're getting. In terms of professional impacts, I

1:06:57.000 --> 1:06:59.120
<v Speaker 1>don't know, that's a good question. I don't know that

1:06:59.200 --> 1:07:03.280
<v Speaker 1>I actually in terms of like creativity or the sort

1:07:03.320 --> 1:07:07.800
<v Speaker 1>of stories you hear about people like, Um, Carrie Molli's or,

1:07:08.120 --> 1:07:10.960
<v Speaker 1>you know, or somebody who's had a sort of Eureka

1:07:11.000 --> 1:07:15.680
<v Speaker 1>moment that's been perhaps influenced by the use of psychedelics. Um.

1:07:16.200 --> 1:07:18.400
<v Speaker 1>I think maybe it's because the last thing I generally

1:07:18.440 --> 1:07:21.520
<v Speaker 1>want to think about when I'm on psychedelics is anything

1:07:21.560 --> 1:07:23.360
<v Speaker 1>to have to do with patents or work. So maybe

1:07:23.400 --> 1:07:25.200
<v Speaker 1>I should try and see if I can have some

1:07:25.680 --> 1:07:28.280
<v Speaker 1>creativity on them. I mean, I definitely credit them with

1:07:29.000 --> 1:07:34.160
<v Speaker 1>a lot of change in sort of personal um attributes

1:07:34.520 --> 1:07:36.520
<v Speaker 1>sort to my life. I mean, I I had a

1:07:36.560 --> 1:07:41.160
<v Speaker 1>long time where I was Um, somebody who didn't really

1:07:41.360 --> 1:07:44.280
<v Speaker 1>have a healthy relationship with alcohol, and I found that

1:07:44.400 --> 1:07:48.640
<v Speaker 1>I um had an experience with pulcibin mushrooms. Actually that

1:07:49.280 --> 1:07:52.480
<v Speaker 1>reframe the way I was viewing my relationship with alcohol.

1:07:52.520 --> 1:07:56.520
<v Speaker 1>And actually that's sort of last time after that that

1:07:56.640 --> 1:08:01.600
<v Speaker 1>I have had any kind of uh use of alcohol, Um,

1:08:01.680 --> 1:08:04.920
<v Speaker 1>and other things that I've had really personal meaning. But no,

1:08:05.040 --> 1:08:08.840
<v Speaker 1>I think I'm gonna have to find an opportunity maybe

1:08:08.920 --> 1:08:14.440
<v Speaker 1>to Um think about some of these pattern issues, what

1:08:14.520 --> 1:08:16.920
<v Speaker 1>sort of reciprocity we are or some of the things

1:08:16.960 --> 1:08:19.280
<v Speaker 1>you asked me that I didn't have very good answers for,

1:08:19.520 --> 1:08:22.760
<v Speaker 1>and uh, maybe I'll find them. Okay. Well, Graham, listen.

1:08:23.120 --> 1:08:25.439
<v Speaker 1>Thank you ever so much both for the work you're

1:08:25.439 --> 1:08:27.640
<v Speaker 1>doing and for the taking the time to speak with

1:08:27.760 --> 1:08:31.240
<v Speaker 1>me and our psychoactive audience. Thank you, even though that

1:08:31.320 --> 1:08:34.799
<v Speaker 1>the briggles was entirely mine, Um, and I'm so thankful

1:08:34.960 --> 1:08:37.560
<v Speaker 1>for being asked to join you in the conversation. I

1:08:37.600 --> 1:08:41.280
<v Speaker 1>hope I see you again in horizons or another conference.

1:08:41.320 --> 1:08:46.719
<v Speaker 1>So I hope to sting. If you're enjoying psychoactive, please

1:08:46.800 --> 1:08:49.000
<v Speaker 1>tell your friends about it, or you can write us

1:08:49.040 --> 1:08:52.120
<v Speaker 1>a review at Apple podcasts or wherever you get your podcasts.

1:08:52.600 --> 1:08:55.000
<v Speaker 1>We love to hear from our listeners. If you'd like

1:08:55.160 --> 1:08:58.040
<v Speaker 1>to share your own stories, comments and ideas, then leave

1:08:58.120 --> 1:09:02.360
<v Speaker 1>us a message at one, three, three, seven, seven nine.

1:09:04.400 --> 1:09:08.639
<v Speaker 1>That's eight, three three psycho zero, or you can email

1:09:08.760 --> 1:09:12.120
<v Speaker 1>us at psychoactive at protozoa dot com or find me

1:09:12.200 --> 1:09:15.200
<v Speaker 1>on twitter at Ethan Natal Man. You can also find

1:09:15.280 --> 1:09:19.439
<v Speaker 1>contact information in our show notes. PSYCHOACTIVE is a production

1:09:19.520 --> 1:09:22.960
<v Speaker 1>of I heart radio and protozoa pictures. It's hosted by

1:09:23.040 --> 1:09:27.360
<v Speaker 1>me Ethan Nadelman. It's produced by Noham Osband and Josh Stain.

1:09:27.680 --> 1:09:32.120
<v Speaker 1>The executive producers are Dylan Golden, Ari Handel, Elizabeth geesus

1:09:32.160 --> 1:09:35.639
<v Speaker 1>and Darren Aronofsky from protozoa pictures, Alex Williams and Matt

1:09:35.720 --> 1:09:39.200
<v Speaker 1>Frederick From my heart radio and me Ethan Nadelman. Our

1:09:39.400 --> 1:09:42.960
<v Speaker 1>Music is by Ari Blucien and a special thanks to

1:09:43.080 --> 1:09:57.679
<v Speaker 1>a Brios F Bianca grimshaw and Robert Deep. Next week

1:09:57.800 --> 1:10:01.360
<v Speaker 1>I'll be talking with Professor Edwards Ainger, author of the

1:10:01.439 --> 1:10:05.559
<v Speaker 1>book drunk who argues that the consumption of alcohol has

1:10:05.720 --> 1:10:10.120
<v Speaker 1>been essential to the evolution of human civilization? You know,

1:10:10.200 --> 1:10:12.240
<v Speaker 1>I look at evidence from other parts of the world,

1:10:13.280 --> 1:10:17.080
<v Speaker 1>that wherever you look, it seems like the first cultivated

1:10:17.240 --> 1:10:21.799
<v Speaker 1>plants were chosen for their psychoactive properties, not for nutrition,

1:10:22.360 --> 1:10:25.400
<v Speaker 1>and so that's a sense in which, quite literally, the

1:10:25.520 --> 1:10:29.840
<v Speaker 1>desired to get intoxicated gave rise to civilization. It's would

1:10:29.840 --> 1:10:32.280
<v Speaker 1>cause on our gatherers to settle down in the first place.

1:10:33.240 --> 1:10:35.560
<v Speaker 1>Subscribe to psychoactive now see it, don't Miss It.